#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-8	Impaired	_
1-2	9-19	prefrontal	_
1-3	20-28	activity	_
1-4	29-31	to	_
1-5	32-40	regulate	_
1-6	41-44	the	_
1-7	45-54	intrinsic	_
1-8	55-72	motivation-action	_
1-9	73-77	link	_
1-10	78-80	in	_
1-11	81-94	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-12	95-96	A	_
1-13	97-101	core	_
1-14	102-109	feature	_
1-15	110-112	of	_
1-16	113-126	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-17	127-128	(	_
1-18	129-132	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-19	133-134	)	_
1-20	135-137	is	_
1-21	138-148	impairment	_
1-22	149-151	in	_
1-23	152-161	intrinsic	_
1-24	162-172	motivation	_
1-25	173-174	.	_

2-1	175-183	Although	_
2-2	184-193	intrinsic	_
2-3	194-204	motivation	_
2-4	205-210	plays	_
2-5	211-213	an	_
2-6	214-223	important	_
2-7	224-228	role	_
2-8	229-231	in	_
2-9	232-241	enhancing	_
2-10	242-253	improvement	_
2-11	254-256	of	_
2-12	257-260	the	_
2-13	261-267	social	_
2-14	268-279	functioning	_
2-15	280-281	,	_
2-16	282-285	its	_
2-17	286-292	neural	_
2-18	293-303	mechanisms	_
2-19	304-306	of	_
2-20	307-317	impairment	_
2-21	318-322	have	_
2-22	323-326	yet	_
2-23	327-329	to	_
2-24	330-332	be	_
2-25	333-342	clarified	_
2-26	343-344	.	_

3-1	345-347	We	_
3-2	348-360	hypothesized	_
3-3	361-365	that	_
3-4	366-374	abnormal	_
3-5	375-383	function	_
3-6	384-386	of	_
3-7	387-390	the	_
3-8	391-405	frontostriatal	_
3-9	406-410	loop	_
3-10	411-421	consisting	_
3-11	422-424	of	_
3-12	425-428	the	_
3-13	429-437	striatum	_
3-14	438-441	and	_
3-15	442-449	lateral	_
3-16	450-460	prefrontal	_
3-17	461-467	cortex	_
3-18	468-469	(	_
3-19	470-474	LPFC	_
3-20	475-476	)	_
3-21	477-480	may	_
3-22	481-483	be	_
3-23	484-491	related	_
3-24	492-494	to	_
3-25	495-503	impaired	_
3-26	504-513	intrinsic	_
3-27	514-524	motivation	_
3-28	525-527	in	_
3-29	528-531	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-30	532-533	.	_

4-1	534-536	We	_
4-2	537-543	tested	_
4-3	544-548	this	_
4-4	549-551	by	_
4-5	552-561	comparing	_
4-6	562-565	the	_
4-7	566-571	brain	_
4-8	572-580	activity	_
4-9	581-589	measured	_
4-10	590-592	by	_
4-11	593-603	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-12	604-612	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-13	613-622	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-14	623-630	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-15	631-634	and	_
4-16	635-645	behavioral	_
4-17	646-656	parameters	_
4-18	657-667	associated	_
4-19	668-672	with	_
4-20	673-681	movement	_
4-21	682-683	,	_
4-22	684-694	motivation	_
4-23	695-696	,	_
4-24	697-700	and	_
4-25	701-710	cognitive	_
4-26	711-718	control	_
4-27	719-726	between	_
4-28	727-729	18	_
4-29	730-736	stable	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-30	737-740	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-31	741-749	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-32	750-753	and	_
4-33	754-756	17	_
4-34	757-764	healthy	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-35	765-772	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-36	773-774	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-37	775-777	HC	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-38	778-779	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-39	780-792	participants	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-40	793-799	during	_
4-41	800-801	a	_
4-42	802-806	task	_
4-43	807-811	that	_
4-44	812-819	elicits	_
4-45	820-829	intrinsic	_
4-46	830-840	motivation	_
4-47	841-842	.	_

5-1	843-845	We	_
5-2	846-850	also	_
5-3	851-859	compared	_
5-4	860-863	the	_
5-5	864-874	functional	_
5-6	875-887	connectivity	_
5-7	888-894	during	_
5-8	895-908	resting-state	_
5-9	909-912	and	_
5-10	913-916	the	_
5-11	917-927	fractional	_
5-12	928-938	anisotropy	_
5-13	939-944	using	_
5-14	945-954	diffusion	_
5-15	955-961	tensor	_
5-16	962-969	imaging	_
5-17	970-978	analysis	_
5-18	979-986	between	_
5-19	987-990	the	_
5-20	991-994	two	_
5-21	995-1001	groups	_
5-22	1002-1003	.	_

6-1	1004-1006	We	_
6-2	1007-1014	adopted	_
6-3	1015-1017	an	_
6-4	1018-1027	enjoyable	_
6-5	1028-1034	timing	_
6-6	1035-1039	task	_
6-7	1040-1042	to	_
6-8	1043-1047	stop	_
6-9	1048-1049	a	_
6-10	1050-1059	stopwatch	_
6-11	1060-1062	at	_
6-12	1063-1065	an	_
6-13	1066-1071	exact	_
6-14	1072-1076	time	_
6-15	1077-1078	,	_
6-16	1079-1084	which	_
6-17	1085-1087	in	_
6-18	1088-1091	our	_
6-19	1092-1100	previous	_
6-20	1101-1106	study	_
6-21	1107-1110	has	_
6-22	1111-1123	demonstrated	_
6-23	1124-1126	to	_
6-24	1127-1133	elicit	_
6-25	1134-1143	intrinsic	_
6-26	1144-1154	motivation	_
6-27	1155-1156	.	_

7-1	1157-1165	Although	_
7-2	1166-1169	the	_
7-3	1170-1181	performance	_
7-4	1182-1187	level	_
7-5	1188-1190	in	_
7-6	1191-1198	general	_
7-7	1199-1202	was	_
7-8	1203-1206	not	_
7-9	1207-1216	different	_
7-10	1217-1224	between	_
7-11	1225-1231	groups	_
7-12	1232-1233	,	_
7-13	1234-1237	the	_
7-14	1238-1241	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-15	1242-1247	group	_
7-16	1248-1257	performed	_
7-17	1258-1263	worse	_
7-18	1264-1268	than	_
7-19	1269-1272	the	_
7-20	1273-1275	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
7-21	1276-1281	group	_
7-22	1282-1284	in	_
7-23	1285-1291	trials	_
7-24	1292-1301	following	_
7-25	1302-1303	“	_
7-26	1304-1313	overshoot	_
7-27	1314-1315	”	_
7-28	1316-1322	errors	_
7-29	1323-1324	(	_
7-30	1325-1329	i.e.	_
7-31	1330-1331	,	_
7-32	1332-1335	the	_
7-33	1336-1344	response	_
7-34	1345-1348	was	_
7-35	1349-1352	too	_
7-36	1353-1357	late	_
7-37	1358-1359	)	_
7-38	1360-1361	.	_

8-1	1362-1365	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-2	1366-1378	participants	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-3	1379-1385	showed	_
8-4	1386-1391	lower	_
8-5	1392-1401	intrinsic	_
8-6	1402-1412	motivation	_
8-7	1413-1415	to	_
8-8	1416-1419	the	_
8-9	1420-1424	task	_
8-10	1425-1429	than	_
8-11	1430-1433	the	_
8-12	1434-1436	HC	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
8-13	1437-1442	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
8-14	1443-1445	in	_
8-15	1446-1448	an	_
8-16	1449-1458	inventory	_
8-17	1459-1465	report	_
8-18	1466-1467	.	_

9-1	1468-1471	The	_
9-2	1472-1480	striatal	_
9-3	1481-1489	activity	_
9-4	1490-1496	during	_
9-5	1497-1500	the	_
9-6	1501-1511	prediction	_
9-7	1512-1514	at	_
9-8	1515-1518	the	_
9-9	1519-1523	task	_
9-10	1524-1527	cue	_
9-11	1528-1534	period	_
9-12	1535-1538	was	_
9-13	1539-1551	consistently	_
9-14	1552-1557	lower	_
9-15	1558-1560	in	_
9-16	1561-1564	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-17	1565-1577	participants	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-18	1578-1582	than	_
9-19	1583-1585	in	_
9-20	1586-1588	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-21	1589-1590	.	_

10-1	1591-1594	The	_
10-2	1595-1599	LPFC	_
10-3	1600-1608	activity	_
10-4	1609-1611	at	_
10-5	1612-1615	the	_
10-6	1616-1620	task	_
10-7	1621-1624	cue	_
10-8	1625-1631	period	_
10-9	1632-1642	positively	_
10-10	1643-1653	correlated	_
10-11	1654-1658	with	_
10-12	1659-1668	intrinsic	_
10-13	1669-1679	motivation	_
10-14	1680-1683	and	_
10-15	1684-1688	also	_
10-16	1689-1693	with	_
10-17	1694-1697	the	_
10-18	1698-1702	rate	_
10-19	1703-1705	of	_
10-20	1706-1713	success	_
10-21	1714-1723	following	_
10-22	1724-1733	overshoot	_
10-23	1734-1740	errors	_
10-24	1741-1743	in	_
10-25	1744-1747	the	_
10-26	1748-1750	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
10-27	1751-1756	group	_
10-28	1757-1758	,	_
10-29	1759-1762	but	_
10-30	1763-1766	not	_
10-31	1767-1769	in	_
10-32	1770-1773	the	_
10-33	1774-1777	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-34	1778-1783	group	_
10-35	1784-1785	.	_

11-1	1786-1789	The	_
11-2	1790-1794	LPFC	_
11-3	1795-1803	activity	_
11-4	1804-1806	at	_
11-5	1807-1810	the	_
11-6	1811-1815	task	_
11-7	1816-1819	cue	_
11-8	1820-1826	period	_
11-9	1827-1830	was	_
11-10	1831-1835	also	_
11-11	1836-1846	positively	_
11-12	1847-1857	correlated	_
11-13	1858-1862	with	_
11-14	1863-1866	the	_
11-15	1867-1875	striatal	_
11-16	1876-1884	activity	_
11-17	1885-1887	in	_
11-18	1888-1892	both	_
11-19	1893-1899	groups	_
11-20	1900-1901	.	_

12-1	1902-1905	The	_
12-2	1906-1914	striatal	_
12-3	1915-1923	activity	_
12-4	1924-1930	during	_
12-5	1931-1934	the	_
12-6	1935-1943	feedback	_
12-7	1944-1950	period	_
12-8	1951-1954	was	_
12-9	1955-1958	not	_
12-10	1959-1972	significantly	_
12-11	1973-1982	different	_
12-12	1983-1990	between	_
12-13	1991-1997	groups	_
12-14	1998-1999	.	_

13-1	2000-2005	These	_
13-2	2006-2013	results	_
13-3	2014-2021	suggest	_
13-4	2022-2026	that	_
13-5	2027-2028	,	_
13-6	2029-2035	unlike	_
13-7	2036-2038	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-8	2039-2040	,	_
13-9	2041-2044	the	_
13-10	2045-2051	neural	_
13-11	2052-2060	activity	_
13-12	2061-2063	in	_
13-13	2064-2067	the	_
13-14	2068-2072	LPFC	_
13-15	2073-2078	fails	_
13-16	2079-2081	to	_
13-17	2082-2089	mediate	_
13-18	2090-2097	between	_
13-19	2098-2108	prediction	_
13-20	2109-2111	of	_
13-21	2112-2119	hedonic	_
13-22	2120-2126	events	_
13-23	2127-2130	and	_
13-24	2131-2140	cognitive	_
13-25	2141-2148	control	_
13-26	2149-2151	of	_
13-27	2152-2158	action	_
13-28	2159-2164	plans	_
13-29	2165-2167	in	_
13-30	2168-2171	SCZ	_
13-31	2172-2173	,	_
13-32	2174-2181	whereas	_
13-33	2182-2185	the	_
13-34	2186-2193	hedonic	_
13-35	2194-2202	response	_
13-36	2203-2205	is	_
13-37	2206-2214	retained	_
13-38	2215-2216	.	_

14-1	2217-2227	Highlights	_
14-2	2228-2231	The	_
14-3	2232-2238	neural	_
14-4	2239-2244	basis	_
14-5	2245-2247	of	_
14-6	2248-2256	impaired	_
14-7	2257-2267	motivation	_
14-8	2268-2270	in	_
14-9	2271-2284	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-10	2285-2287	is	_
14-11	2288-2296	examined	_
14-12	2297-2302	using	_
14-13	2303-2307	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
14-14	2308-2309	.	_

15-1	2310-2313	The	_
15-2	2314-2321	hedonic	_
15-3	2322-2330	response	_
15-4	2331-2333	to	_
15-5	2334-2335	a	_
15-6	2336-2344	feedback	_
15-7	2345-2347	in	_
15-8	2348-2351	the	_
15-9	2352-2360	striatum	_
15-10	2361-2363	is	_
15-11	2364-2372	retained	_
15-12	2373-2375	in	_
15-13	2376-2389	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-14	2390-2391	.	_

16-1	2392-2403	Translating	_
16-2	2404-2411	hedonic	_
16-3	2412-2418	events	_
16-4	2419-2421	to	_
16-5	2422-2428	action	_
16-6	2429-2434	plans	_
16-7	2435-2437	is	_
16-8	2438-2445	impeded	_
16-9	2446-2448	by	_
16-10	2449-2453	poor	_
16-11	2454-2463	cognitive	_
16-12	2464-2471	control	_
16-13	2472-2473	.	_

17-1	2474-2477	The	_
17-2	2478-2487	cognitive	_
17-3	2488-2495	control	_
17-4	2496-2506	impairment	_
17-5	2507-2509	is	_
17-6	2510-2520	associated	_
17-7	2521-2525	with	_
17-8	2526-2533	altered	_
17-9	2534-2544	prefrontal	_
17-10	2545-2553	function	_
17-11	2554-2555	.	_

18-1	2556-2565	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
18-2	2566-2569	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
18-3	2570-2577	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
18-4	2578-2590	Participants	_
18-5	2591-2599	Eighteen	_
18-6	2600-2608	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-7	2609-2613	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-8	2614-2617	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
18-9	2618-2627	diagnosed	_
18-10	2628-2630	in	_
18-11	2631-2641	accordance	_
18-12	2642-2646	with	_
18-13	2647-2650	the	_
18-14	2651-2660	DSM-IV-TR	_
18-15	2661-2669	criteria	_
18-16	2670-2674	with	_
18-17	2675-2679	mild	_
18-18	2680-2694	symptomatology	_
18-19	2695-2699	were	_
18-20	2700-2709	recruited	_
18-21	2710-2714	from	_
18-22	2715-2726	outpatients	_
18-23	2727-2729	of	_
18-24	2730-2738	National	_
18-25	2739-2745	Center	_
18-26	2746-2754	Hospital	_
18-27	2755-2756	,	_
18-28	2757-2765	National	_
18-29	2766-2772	Center	_
18-30	2773-2775	of	_
18-31	2776-2785	Neurology	_
18-32	2786-2789	and	_
18-33	2790-2800	Psychiatry	_
18-34	2801-2802	(	_
18-35	2803-2807	NCNP	_
18-36	2808-2809	)	_
18-37	2810-2811	.	_

19-1	2812-2815	All	_
19-2	2816-2824	patients	_
19-3	2825-2829	gave	_
19-4	2830-2837	written	_
19-5	2838-2846	informed	_
19-6	2847-2854	consent	_
19-7	2855-2856	.	_

20-1	2857-2860	The	_
20-2	2861-2865	mean	_
20-3	2866-2871	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
20-4	2872-2877	total	_
20-5	2878-2883	score	_
20-6	2884-2887	was	_
20-7	2888-2892	43.4	_
20-8	2893-2894	±	_
20-9	2895-2898	8.0	_
20-10	2899-2902	and	_
20-11	2903-2906	the	_
20-12	2907-2911	mean	_
20-13	2912-2920	duration	_
20-14	2921-2923	of	_
20-15	2924-2931	illness	_
20-16	2932-2935	was	_
20-17	2936-2939	8.7	_
20-18	2940-2941	±	_
20-19	2942-2945	4.7	_
20-20	2946-2951	years	_
20-21	2952-2962	suggesting	_
20-22	2963-2967	that	_
20-23	2968-2971	the	_
20-24	2972-2980	patients	_
20-25	2981-2985	were	_
20-26	2986-2996	clinically	_
20-27	2997-3003	stable	_
20-28	3004-3007	and	_
20-29	3008-3017	treatment	_
20-30	3018-3028	responsive	_
20-31	3029-3040	considering	_
20-32	3041-3044	the	_
20-33	3045-3055	relatively	_
20-34	3056-3061	short	_
20-35	3062-3070	duration	_
20-36	3071-3073	of	_
20-37	3074-3081	illness	_
20-38	3082-3083	.	_

21-1	3084-3093	Seventeen	_
21-2	3094-3096	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-3	3097-3105	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-4	3106-3107	,	_
21-5	3108-3115	matched	_
21-6	3116-3118	on	_
21-7	3119-3122	age	_
21-8	3123-3126	and	_
21-9	3127-3130	sex	_
21-10	3131-3134	and	_
21-11	3135-3142	without	_
21-12	3143-3146	any	_
21-13	3147-3154	history	_
21-14	3155-3157	of	_
21-15	3158-3169	psychiatric	_
21-16	3170-3173	and	_
21-17	3174-3186	neurological	_
21-18	3187-3194	illness	_
21-19	3195-3196	,	_
21-20	3197-3201	also	_
21-21	3202-3211	consented	_
21-22	3212-3214	to	_
21-23	3215-3226	participate	_
21-24	3227-3229	in	_
21-25	3230-3233	the	_
21-26	3234-3239	study	_
21-27	3240-3241	.	_

22-1	3242-3245	The	_
22-2	3246-3251	study	_
22-3	3252-3255	was	_
22-4	3256-3264	approved	_
22-5	3265-3267	by	_
22-6	3268-3271	the	_
22-7	3272-3279	ethical	_
22-8	3280-3289	committee	_
22-9	3290-3292	of	_
22-10	3293-3297	NCNP	_
22-11	3298-3299	.	_

23-1	3300-3303	The	_
23-2	3304-3315	demographic	_
23-3	3316-3319	and	_
23-4	3320-3328	clinical	_
23-5	3329-3344	characteristics	_
23-6	3345-3347	in	_
23-7	3348-3352	both	_
23-8	3353-3359	groups	_
23-9	3360-3363	are	_
23-10	3364-3369	shown	_
23-11	3370-3372	in	_
23-12	3373-3378	Table	_
23-13	3379-3380	1	_
23-14	3381-3384	and	_
23-15	3385-3398	Supplementary	_
23-16	3399-3406	Methods	_
23-17	3407-3408	.	_

24-1	3409-3421	Experimental	_
24-2	3422-3426	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
24-3	3427-3429	In	_
24-4	3430-3433	the	_
24-5	3434-3443	stopwatch	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
24-6	3444-3445	(	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
24-7	3446-3448	SW	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
24-8	3449-3450	)	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
24-9	3451-3455	task	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
24-10	3456-3457	,	_
24-11	3458-3459	a	_
24-12	3460-3462	SW	_
24-13	3463-3471	depicted	_
24-14	3472-3474	in	_
24-15	3475-3478	the	_
24-16	3479-3485	screen	_
24-17	3486-3493	started	_
24-18	3494-3507	automatically	_
24-19	3508-3509	,	_
24-20	3510-3513	and	_
24-21	3514-3517	the	_
24-22	3518-3522	goal	_
24-23	3523-3526	was	_
24-24	3527-3529	to	_
24-25	3530-3535	press	_
24-26	3536-3537	a	_
24-27	3538-3544	button	_
24-28	3545-3549	with	_
24-29	3550-3553	the	_
24-30	3554-3559	right	_
24-31	3560-3565	thumb	_
24-32	3566-3572	within	_
24-33	3573-3575	50	_
24-34	3576-3578	ms	_
24-35	3579-3581	of	_
24-36	3582-3585	the	_
24-37	3586-3589	5-s	_
24-38	3590-3594	time	_
24-39	3595-3600	point	_
24-40	3601-3602	(	_
24-41	3603-3606	Fig	_
24-42	3607-3608	.	_

25-1	3609-3611	1A	_
25-2	3612-3613	)	_
25-3	3614-3615	.	_

26-1	3616-3619	The	_
26-2	3620-3631	accumulated	_
26-3	3632-3638	number	_
26-4	3639-3641	of	_
26-5	3642-3652	successful	_
26-6	3653-3659	trials	_
26-7	3660-3662	in	_
26-8	3663-3666	the	_
26-9	3667-3669	SW	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
26-10	3670-3674	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
26-11	3675-3678	was	_
26-12	3679-3691	continuously	_
26-13	3692-3701	presented	_
26-14	3702-3704	at	_
26-15	3705-3708	the	_
26-16	3709-3714	upper	_
26-17	3715-3720	right	_
26-18	3721-3727	corner	_
26-19	3728-3730	of	_
26-20	3731-3734	the	_
26-21	3735-3741	screen	_
26-22	3742-3745	and	_
26-23	3746-3749	was	_
26-24	3750-3757	updated	_
26-25	3758-3761	1.5	_
26-26	3762-3763	s	_
26-27	3764-3769	after	_
26-28	3770-3773	the	_
26-29	3774-3780	button	_
26-30	3781-3786	press	_
26-31	3787-3791	only	_
26-32	3792-3796	when	_
26-33	3797-3800	the	_
26-34	3801-3812	participant	_
26-35	3813-3822	succeeded	_
26-36	3823-3825	in	_
26-37	3826-3834	stopping	_
26-38	3835-3838	the	_
26-39	3839-3841	SW	_
26-40	3842-3849	display	_
26-41	3850-3857	between	_
26-42	3858-3862	4.95	_
26-43	3863-3864	s	_
26-44	3865-3868	and	_
26-45	3869-3873	5.05	_
26-46	3874-3876	s.	_
26-47	3877-3880	The	_
26-48	3881-3888	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
26-49	3889-3893	task	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
26-50	3894-3897	was	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
26-51	3898-3899	a	_
26-52	3900-3910	watch-stop	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
26-53	3911-3912	(	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
26-54	3913-3915	WS	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
26-55	3916-3917	)	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
26-56	3918-3922	task	http://maven.renci.org/NeuroBridge/neurobridge#MismatchNegativityTask
26-57	3923-3924	,	_
26-58	3925-3927	in	_
26-59	3928-3933	which	_
26-60	3934-3946	participants	_
26-61	3947-3956	passively	_
26-62	3957-3963	viewed	_
26-63	3964-3965	a	_
26-64	3966-3968	SW	http://maven.renci.org/NeuroBridge/neurobridge#Thing
26-65	3969-3972	and	_
26-66	3973-3977	were	_
26-67	3978-3983	asked	_
26-68	3984-3986	to	_
26-69	3987-3993	simply	_
26-70	3994-3999	press	_
26-71	4000-4001	a	_
26-72	4002-4008	button	_
26-73	4009-4013	when	_
26-74	4014-4016	it	_
26-75	4017-4030	automatically	_
26-76	4031-4038	stopped	_
26-77	4039-4040	.	_

27-1	4041-4044	The	_
27-2	4045-4047	SW	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
27-3	4048-4052	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
27-4	4053-4056	was	_
27-5	4057-4067	considered	_
27-6	4068-4072	more	_
27-7	4073-4083	motivating	_
27-8	4084-4088	than	_
27-9	4089-4092	the	_
27-10	4093-4095	WS	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
27-11	4096-4100	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
27-12	4101-4102	.	_

28-1	4103-4104	A	_
28-2	4105-4112	session	_
28-3	4113-4121	consists	_
28-4	4122-4124	of	_
28-5	4125-4127	30	_
28-6	4128-4130	SW	http://maven.renci.org/NeuroBridge/neurobridge#Thing
28-7	4131-4134	and	_
28-8	4135-4137	30	_
28-9	4138-4140	WS	_
28-10	4141-4147	trials	_
28-11	4148-4149	,	_
28-12	4150-4155	which	_
28-13	4156-4160	were	_
28-14	4161-4175	pseudorandomly	_
28-15	4176-4186	intermixed	_
28-16	4187-4190	and	_
28-17	4191-4195	both	_
28-18	4196-4201	tasks	_
28-19	4202-4206	were	_
28-20	4207-4215	preceded	_
28-21	4216-4218	by	_
28-22	4219-4220	a	_
28-23	4221-4224	cue	_
28-24	4225-4229	that	_
28-25	4230-4239	indicates	_
28-26	4240-4245	which	_
28-27	4246-4248	of	_
28-28	4249-4252	the	_
28-29	4253-4256	two	_
28-30	4257-4262	tasks	_
28-31	4263-4267	will	_
28-32	4268-4270	be	_
28-33	4271-4280	displayed	_
28-34	4281-4282	(	_
28-35	4283-4296	Supplementary	_
28-36	4297-4304	Methods	_
28-37	4305-4306	)	_
28-38	4307-4308	.	_

29-1	4309-4319	Behavioral	_
29-2	4320-4328	measures	_
29-3	4329-4331	To	_
29-4	4332-4339	measure	_
29-5	4340-4343	the	_
29-6	4344-4356	participants	_
29-7	4357-4358	'	_
29-8	4359-4369	behavioral	_
29-9	4370-4378	response	_
29-10	4379-4389	properties	_
29-11	4390-4391	,	_
29-12	4392-4394	we	_
29-13	4395-4403	obtained	_
29-14	4404-4407	the	_
29-15	4408-4416	reaction	_
29-16	4417-4421	time	_
29-17	4422-4423	(	_
29-18	4424-4426	RT	_
29-19	4427-4428	)	_
29-20	4429-4431	in	_
29-21	4432-4435	the	_
29-22	4436-4438	WS	_
29-23	4439-4443	task	_
29-24	4444-4445	.	_

30-1	4446-4449	The	_
30-2	4450-4452	RT	_
30-3	4453-4455	in	_
30-4	4456-4459	the	_
30-5	4460-4462	WS	_
30-6	4463-4468	trial	_
30-7	4469-4472	was	_
30-8	4473-4476	the	_
30-9	4477-4483	period	_
30-10	4484-4488	from	_
30-11	4489-4492	the	_
30-12	4493-4497	time	_
30-13	4498-4502	that	_
30-14	4503-4506	the	_
30-15	4507-4516	stopwatch	_
30-16	4517-4530	automatically	_
30-17	4531-4538	stopped	_
30-18	4539-4541	to	_
30-19	4542-4546	when	_
30-20	4547-4550	the	_
30-21	4551-4562	participant	_
30-22	4563-4570	pressed	_
30-23	4571-4574	the	_
30-24	4575-4581	button	_
30-25	4582-4583	(	_
30-26	4584-4590	always	_
30-27	4591-4599	positive	_
30-28	4600-4607	because	_
30-29	4608-4614	button	_
30-30	4615-4620	press	_
30-31	4621-4624	was	_
30-32	4625-4628	not	_
30-33	4629-4636	allowed	_
30-34	4637-4643	before	_
30-35	4644-4647	the	_
30-36	4648-4657	stopwatch	_
30-37	4658-4665	stopped	_
30-38	4666-4667	)	_
30-39	4668-4669	.	_

31-1	4670-4672	On	_
31-2	4673-4676	the	_
31-3	4677-4682	other	_
31-4	4683-4687	hand	_
31-5	4688-4689	,	_
31-6	4690-4692	in	_
31-7	4693-4696	the	_
31-8	4697-4699	SW	http://maven.renci.org/NeuroBridge/neurobridge#Thing
31-9	4700-4704	task	_
31-10	4705-4706	,	_
31-11	4707-4709	we	_
31-12	4710-4720	calculated	_
31-13	4721-4724	the	_
31-14	4725-4731	Timing	_
31-15	4732-4737	Error	_
31-16	4738-4739	(	_
31-17	4740-4742	TE	_
31-18	4743-4744	)	_
31-19	4745-4746	.	_

32-1	4747-4750	The	_
32-2	4751-4753	TE	_
32-3	4754-4756	in	_
32-4	4757-4760	the	_
32-5	4761-4763	SW	_
32-6	4764-4769	trial	_
32-7	4770-4773	was	_
32-8	4774-4781	defined	_
32-9	4782-4784	as	_
32-10	4785-4788	the	_
32-11	4789-4793	time	_
32-12	4794-4798	from	_
32-13	4799-4803	5.00	_
32-14	4804-4805	s	_
32-15	4806-4807	(	_
32-16	4808-4813	ideal	_
32-17	4814-4818	time	_
32-18	4819-4821	to	_
32-19	4822-4824	be	_
32-20	4825-4832	stopped	_
32-21	4833-4834	)	_
32-22	4835-4837	to	_
32-23	4838-4842	when	_
32-24	4843-4846	the	_
32-25	4847-4858	participant	_
32-26	4859-4866	pressed	_
32-27	4867-4870	the	_
32-28	4871-4877	button	_
32-29	4878-4880	to	_
32-30	4881-4885	stop	_
32-31	4886-4889	the	_
32-32	4890-4899	stopwatch	_
32-33	4900-4901	(	_
32-34	4902-4910	positive	_
32-35	4911-4913	TE	_
32-36	4914-4917	for	_
32-37	4918-4925	stopped	_
32-38	4926-4930	time	_
32-39	4931-4933	of	_
32-40	4934-4935	>	_
32-41	4936-4940	5.00	_
32-42	4941-4942	s	_
32-43	4943-4944	,	_
32-44	4945-4948	and	_
32-45	4949-4957	negative	_
32-46	4958-4960	TE	_
32-47	4961-4964	for	_
32-48	4965-4972	stopped	_
32-49	4973-4977	time	_
32-50	4978-4980	of	_
32-51	4981-4982	<	_
32-52	4983-4987	5.00	_
32-53	4988-4989	s	_
32-54	4990-4991	)	_
32-55	4992-4993	.	_

33-1	4994-4998	Also	_
33-2	4999-5000	,	_
33-3	5001-5003	to	_
33-4	5004-5011	measure	_
33-5	5012-5015	how	_
33-6	5016-5023	quickly	_
33-7	5024-5026	or	_
33-8	5027-5033	slowly	_
33-9	5034-5037	the	_
33-10	5038-5050	participants	_
33-11	5051-5058	pressed	_
33-12	5059-5062	the	_
33-13	5063-5069	button	_
33-14	5070-5072	in	_
33-15	5073-5082	erroneous	_
33-16	5083-5085	SW	_
33-17	5086-5092	trials	_
33-18	5093-5094	,	_
33-19	5095-5097	we	_
33-20	5098-5108	classified	_
33-21	5109-5112	the	_
33-22	5113-5122	erroneous	_
33-23	5123-5125	SW	_
33-24	5126-5132	trials	_
33-25	5133-5137	into	_
33-26	5138-5141	two	_
33-27	5142-5147	types	_
33-28	5148-5149	:	_
33-29	5150-5160	Undershoot	_
33-30	5161-5164	for	_
33-31	5165-5168	the	_
33-32	5169-5174	trial	_
33-33	5175-5179	with	_
33-34	5180-5182	TE	_
33-35	5183-5184	<	_
33-36	5185-5186	−	_
33-37	5187-5191	0.05	_
33-38	5192-5193	s	_
33-39	5194-5195	(	_
33-40	5196-5199	i.e	_
33-41	5200-5201	.	_

34-1	5202-5205	the	_
34-2	5206-5213	stopped	_
34-3	5214-5218	time	_
34-4	5219-5220	<	_
34-5	5221-5225	4.95	_
34-6	5226-5227	s	_
34-7	5228-5229	)	_
34-8	5230-5233	and	_
34-9	5234-5243	Overshoot	_
34-10	5244-5247	for	_
34-11	5248-5251	the	_
34-12	5252-5257	trial	_
34-13	5258-5262	with	_
34-14	5263-5265	TE	_
34-15	5266-5267	>	_
34-16	5268-5269	+	_
34-17	5270-5274	0.05	_
34-18	5275-5276	s	_
34-19	5277-5278	(	_
34-20	5279-5282	i.e	_
34-21	5283-5284	.	_

35-1	5285-5288	the	_
35-2	5289-5296	stopped	_
35-3	5297-5301	time	_
35-4	5302-5303	>	_
35-5	5304-5308	5.05	_
35-6	5309-5310	s	_
35-7	5311-5312	)	_
35-8	5313-5314	,	_
35-9	5315-5318	and	_
35-10	5319-5327	averaged	_
35-11	5328-5331	the	_
35-12	5332-5334	TE	_
35-13	5335-5336	s	_
35-14	5337-5340	for	_
35-15	5341-5351	Undershoot	_
35-16	5352-5355	and	_
35-17	5356-5365	Overshoot	_
35-18	5366-5372	trials	_
35-19	5373-5383	separately	_
35-20	5384-5385	.	_

36-1	5386-5397	Furthermore	_
36-2	5398-5399	,	_
36-3	5400-5402	to	_
36-4	5403-5410	examine	_
36-5	5411-5418	whether	_
36-6	5419-5422	the	_
36-7	5423-5425	TE	_
36-8	5426-5436	correction	_
36-9	5437-5446	following	_
36-10	5447-5457	Undershoot	_
36-11	5458-5460	or	_
36-12	5461-5470	Overshoot	_
36-13	5471-5477	trials	_
36-14	5478-5480	in	_
36-15	5481-5484	SCZ	_
36-16	5485-5488	was	_
36-17	5489-5500	appropriate	_
36-18	5501-5503	or	_
36-19	5504-5507	not	_
36-20	5508-5509	,	_
36-21	5510-5512	we	_
36-22	5513-5521	compared	_
36-23	5522-5525	the	_
36-24	5526-5537	performance	_
36-25	5538-5544	levels	_
36-26	5545-5547	in	_
36-27	5548-5551	the	_
36-28	5552-5554	SW	_
36-29	5555-5561	trials	_
36-30	5562-5571	following	_
36-31	5572-5582	Undershoot	_
36-32	5583-5585	or	_
36-33	5586-5595	Overshoot	_
36-34	5596-5602	trials	_
36-35	5603-5610	between	_
36-36	5611-5614	SCZ	_
36-37	5615-5618	and	_
36-38	5619-5621	HC	_
36-39	5622-5623	.	_

37-1	5624-5627	The	_
37-2	5628-5632	rate	_
37-3	5633-5635	of	_
37-4	5636-5643	Success	_
37-5	5644-5645	,	_
37-6	5646-5656	Undershoot	_
37-7	5657-5660	and	_
37-8	5661-5670	Overshoot	_
37-9	5671-5673	SW	_
37-10	5674-5680	trials	_
37-11	5681-5690	following	_
37-12	5691-5693	an	_
37-13	5694-5704	Undershoot	_
37-14	5705-5707	or	_
37-15	5708-5717	Overshoot	_
37-16	5718-5723	trial	_
37-17	5724-5727	was	_
37-18	5728-5738	calculated	_
37-19	5739-5741	by	_
37-20	5742-5751	averaging	_
37-21	5752-5755	the	_
37-22	5756-5761	rates	_
37-23	5762-5766	from	_
37-24	5767-5771	each	_
37-25	5772-5783	participant	_
37-26	5784-5786	in	_
37-27	5787-5791	each	_
37-28	5792-5797	group	_
37-29	5798-5799	.	_

38-1	5800-5803	For	_
38-2	5804-5808	each	_
38-3	5809-5820	participant	_
38-4	5821-5822	,	_
38-5	5823-5825	we	_
38-6	5826-5836	calculated	_
38-7	5837-5840	the	_
38-8	5841-5846	rates	_
38-9	5847-5849	by	_
38-10	5850-5858	dividing	_
38-11	5859-5862	the	_
38-12	5863-5869	number	_
38-13	5870-5872	SW	_
38-14	5873-5879	trials	_
38-15	5880-5883	per	_
38-16	5884-5888	type	_
38-17	5889-5890	(	_
38-18	5891-5898	Success	_
38-19	5899-5900	,	_
38-20	5901-5911	Undershoot	_
38-21	5912-5914	or	_
38-22	5915-5924	Overshoot	_
38-23	5925-5926	)	_
38-24	5927-5936	following	_
38-25	5937-5939	an	_
38-26	5940-5950	Undershoot	_
38-27	5951-5953	or	_
38-28	5954-5963	Overshoot	_
38-29	5964-5969	trial	_
38-30	5970-5972	by	_
38-31	5973-5976	the	_
38-32	5977-5982	total	_
38-33	5983-5989	number	_
38-34	5990-5992	of	_
38-35	5993-6003	Undershoot	_
38-36	6004-6006	or	_
38-37	6007-6016	Overshoot	_
38-38	6017-6023	trials	_
38-39	6024-6025	.	_

39-1	6026-6037	Measurement	_
39-2	6038-6040	of	_
39-3	6041-6050	intrinsic	_
39-4	6051-6061	motivation	_
39-5	6062-6064	In	_
39-6	6065-6070	order	_
39-7	6071-6073	to	_
39-8	6074-6080	assess	_
39-9	6081-6085	each	_
39-10	6086-6097	participant	_
39-11	6098-6100	's	_
39-12	6101-6110	intrinsic	_
39-13	6111-6121	motivation	_
39-14	6122-6125	for	_
39-15	6126-6130	each	_
39-16	6131-6135	task	_
39-17	6136-6137	,	_
39-18	6138-6140	we	_
39-19	6141-6145	used	_
39-20	6146-6149	the	_
39-21	6150-6159	intrinsic	_
39-22	6160-6170	motivation	_
39-23	6171-6180	inventory	_
39-24	6181-6182	(	_
39-25	6183-6186	IMI	_
39-26	6187-6188	)	_
39-27	6189-6198	developed	_
39-28	6199-6201	by	_
39-29	6202-6203	.	_

40-1	6204-6207	IMI	_
40-2	6208-6210	is	http://maven.renci.org/NeuroBridge/neurobridge#Actigraph
40-3	6211-6212	a	_
40-4	6213-6226	self-reported	_
40-5	6227-6240	questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#Questionnaire
40-6	6241-6242	,	_
40-7	6243-6248	which	_
40-8	6249-6257	consists	_
40-9	6258-6260	of	_
40-10	6261-6263	21	_
40-11	6264-6273	questions	_
40-12	6274-6276	on	_
40-13	6277-6278	a	_
40-14	6279-6290	seven-point	_
40-15	6291-6297	Likert	_
40-16	6298-6303	scale	_
40-17	6304-6307	for	_
40-18	6308-6312	each	_
40-19	6313-6317	task	_
40-20	6318-6319	.	_

41-1	6320-6323	IMI	_
41-2	6324-6332	provides	_
41-3	6333-6338	three	_
41-4	6339-6348	subscales	_
41-5	6349-6350	,	_
41-6	6351-6352	“	_
41-7	6353-6361	interest	_
41-8	6362-6365	and	_
41-9	6366-6375	enjoyment	_
41-10	6376-6377	”	_
41-11	6378-6379	,	_
41-12	6380-6381	“	_
41-13	6382-6388	choice	_
41-14	6389-6390	”	_
41-15	6391-6394	and	_
41-16	6395-6396	“	_
41-17	6397-6402	value	_
41-18	6403-6404	”	_
41-19	6405-6406	,	_
41-20	6407-6412	which	_
41-21	6413-6416	are	_
41-22	6417-6427	calculated	_
41-23	6428-6432	from	_
41-24	6433-6436	the	_
41-25	6437-6450	corresponding	_
41-26	6451-6452	7	_
41-27	6453-6462	questions	_
41-28	6463-6464	.	_

42-1	6465-6467	In	_
42-2	6468-6472	this	_
42-3	6473-6478	study	_
42-4	6479-6480	,	_
42-5	6481-6489	subscale	_
42-6	6490-6496	scores	_
42-7	6497-6499	of	_
42-8	6500-6501	“	_
42-9	6502-6508	choice	_
42-10	6509-6510	”	_
42-11	6511-6515	were	_
42-12	6516-6524	excluded	_
42-13	6525-6529	from	_
42-14	6530-6533	the	_
42-15	6534-6537	IMI	_
42-16	6538-6544	scores	_
42-17	6545-6547	as	_
42-18	6548-6551	the	_
42-19	6552-6556	task	_
42-20	6557-6560	was	_
42-21	6561-6564	not	_
42-22	6565-6567	of	_
42-23	6568-6572	free	_
42-24	6573-6579	choice	_
42-25	6580-6581	.	_

43-1	6582-6584	We	_
43-2	6585-6595	considered	_
43-3	6596-6599	the	_
43-4	6600-6606	summed	_
43-5	6607-6612	score	_
43-6	6613-6615	of	_
43-7	6616-6617	“	_
43-8	6618-6626	interest	_
43-9	6627-6630	and	_
43-10	6631-6640	enjoyment	_
43-11	6641-6642	”	_
43-12	6643-6646	and	_
43-13	6647-6648	“	_
43-14	6649-6654	value	_
43-15	6655-6656	”	_
43-16	6657-6660	for	_
43-17	6661-6663	SW	_
43-18	6664-6668	task	_
43-19	6669-6671	as	_
43-20	6672-6673	a	_
43-21	6674-6681	measure	_
43-22	6682-6684	of	_
43-23	6685-6694	intrinsic	_
43-24	6695-6705	motivation	_
43-25	6706-6711	after	_
43-26	6712-6723	subtracting	_
43-27	6724-6727	the	_
43-28	6728-6734	summed	_
43-29	6735-6740	score	_
43-30	6741-6744	for	_
43-31	6745-6748	the	_
43-32	6749-6756	control	_
43-33	6757-6758	(	_
43-34	6759-6761	WS	_
43-35	6762-6763	)	_
43-36	6764-6768	task	_
43-37	6769-6770	.	_

44-1	6771-6775	Scan	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
44-2	6776-6785	procedure	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
44-3	6786-6787	,	_
44-4	6788-6791	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
44-5	6792-6796	data	_
44-6	6797-6808	acquisition	_
44-7	6809-6812	All	_
44-8	6813-6823	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
44-9	6824-6827	and	_
44-10	6828-6838	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-11	6839-6842	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
44-12	6843-6847	data	_
44-13	6848-6852	were	_
44-14	6853-6862	collected	_
44-15	6863-6868	using	_
44-16	6869-6870	a	_
44-17	6871-6874	3-T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
44-18	6875-6880	Verio	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
44-19	6881-6884	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
44-20	6885-6892	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
44-21	6893-6894	(	_
44-22	6895-6902	Siemens	_
44-23	6903-6904	)	_
44-24	6905-6909	with	_
44-25	6910-6913	the	_
44-26	6914-6924	32-channel	_
44-27	6925-6929	head	_
44-28	6930-6934	coil	_
44-29	6935-6937	at	_
44-30	6938-6941	the	_
44-31	6942-6953	Integrative	_
44-32	6954-6959	Brain	_
44-33	6960-6967	Imaging	_
44-34	6968-6974	Center	_
44-35	6975-6976	,	_
44-36	6977-6981	NCNP	_
44-37	6982-6983	.	_

45-1	6984-6991	Firstly	_
45-2	6992-6993	,	_
45-3	6994-6997	the	_
45-4	6998-7007	following	_
45-5	7008-7018	parameters	_
45-6	7019-7023	were	_
45-7	7024-7028	used	_
45-8	7029-7032	for	_
45-9	7033-7048	high-resolution	_
45-10	7049-7060	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-11	7061-7071	volumetric	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-12	7072-7074	3D	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-13	7075-7076	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-14	7077-7090	3DT1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-15	7091-7092	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-16	7093-7099	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-17	7100-7107	axially	_
45-18	7108-7109	:	_
45-19	7110-7120	repetition	_
45-20	7121-7125	time	_
45-21	7126-7127	(	_
45-22	7128-7130	TR	_
45-23	7131-7132	)	_
45-24	7133-7138	/echo	_
45-25	7139-7143	time	_
45-26	7144-7145	(	_
45-27	7146-7148	TE	_
45-28	7149-7150	)	_
45-29	7151-7152	=	_
45-30	7153-7162	2300/2.95	_
45-31	7163-7165	ms	_
45-32	7166-7167	,	_
45-33	7168-7171	256	_
45-34	7172-7173	×	_
45-35	7174-7177	256	_
45-36	7178-7184	matrix	_
45-37	7185-7186	,	_
45-38	7187-7189	9°	_
45-39	7190-7194	flip	_
45-40	7195-7200	angle	_
45-41	7201-7202	,	_
45-42	7203-7208	voxel	_
45-43	7209-7213	size	_
45-44	7214-7215	=	_
45-45	7216-7219	1.1	_
45-46	7220-7221	×	_
45-47	7222-7225	1.1	_
45-48	7226-7227	×	_
45-49	7228-7231	1.2	_
45-50	7232-7235	mm3	_
45-51	7236-7239	and	_
45-52	7240-7243	176	_
45-53	7244-7250	slices	_
45-54	7251-7258	without	_
45-55	7259-7270	inter-slice	_
45-56	7271-7274	gap	_
45-57	7275-7276	.	_

46-1	7277-7283	Second	_
46-2	7284-7285	,	_
46-3	7286-7296	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
46-4	7297-7313	imaging—gradient	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
46-5	7314-7318	echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
46-6	7319-7320	,	_
46-7	7321-7323	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-8	7324-7325	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-9	7326-7335	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-10	7336-7347	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-11	7348-7354	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-12	7355-7356	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-13	7357-7360	EPI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-14	7361-7362	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-15	7363-7367	with	_
46-16	7368-7373	blood	_
46-17	7374-7385	oxygenation	_
46-18	7386-7401	level-dependent	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
46-19	7402-7403	(	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
46-20	7404-7408	BOLD	_
46-21	7409-7410	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
46-22	7411-7424	contrast—were	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
46-23	7425-7433	acquired	_
46-24	7434-7440	during	_
46-25	7441-7444	the	_
46-26	7445-7447	SW	http://maven.renci.org/NeuroBridge/neurobridge#Thing
46-27	7448-7451	and	_
46-28	7452-7454	WS	http://maven.renci.org/NeuroBridge/neurobridge#Thing
46-29	7455-7460	tasks	_
46-30	7461-7462	.	_

47-1	7463-7472	Forty-two	_
47-2	7473-7483	contiguous	_
47-3	7484-7495	interleaved	_
47-4	7496-7507	transversal	_
47-5	7508-7514	slices	_
47-6	7515-7519	were	_
47-7	7520-7528	acquired	_
47-8	7529-7531	in	_
47-9	7532-7536	each	_
47-10	7537-7543	volume	_
47-11	7544-7545	,	_
47-12	7546-7550	with	_
47-13	7551-7552	a	_
47-14	7553-7558	slice	_
47-15	7559-7568	thickness	_
47-16	7569-7571	of	_
47-17	7572-7573	3	_
47-18	7574-7576	mm	_
47-19	7577-7580	and	_
47-20	7581-7583	no	_
47-21	7584-7587	gap	_
47-22	7588-7589	(	_
47-23	7590-7595	TR/TE	_
47-24	7596-7597	=	_
47-25	7598-7605	2500/25	_
47-26	7606-7608	ms	_
47-27	7609-7610	,	_
47-28	7611-7614	90°	_
47-29	7615-7619	flip	_
47-30	7620-7625	angle	_
47-31	7626-7627	,	_
47-32	7628-7633	field	_
47-33	7634-7636	of	_
47-34	7637-7641	view	_
47-35	7642-7643	=	_
47-36	7644-7647	192	_
47-37	7648-7649	×	_
47-38	7650-7653	192	_
47-39	7654-7657	mm2	_
47-40	7658-7659	,	_
47-41	7660-7662	64	_
47-42	7663-7664	×	_
47-43	7665-7667	64	_
47-44	7668-7674	matrix	_
47-45	7675-7676	)	_
47-46	7677-7678	.	_

48-1	7679-7684	Slice	_
48-2	7685-7696	orientation	_
48-3	7697-7700	was	_
48-4	7701-7707	tilted	_
48-5	7708-7709	−	_
48-6	7710-7713	30°	_
48-7	7714-7718	from	_
48-8	7719-7722	the	_
48-9	7723-7728	AC–PC	_
48-10	7729-7733	line	_
48-11	7734-7735	.	_

49-1	7736-7738	We	_
49-2	7739-7748	discarded	_
49-3	7749-7752	the	_
49-4	7753-7758	first	_
49-5	7759-7764	three	_
49-6	7765-7771	images	_
49-7	7772-7778	before	_
49-8	7779-7783	data	_
49-9	7784-7794	processing	_
49-10	7795-7798	and	_
49-11	7799-7803	used	_
49-12	7804-7815	statistical	_
49-13	7816-7824	analysis	_
49-14	7825-7827	to	_
49-15	7828-7838	compensate	_
49-16	7839-7842	for	_
49-17	7843-7846	the	_
49-18	7847-7849	T1	_
49-19	7850-7860	saturation	_
49-20	7861-7868	effects	_
49-21	7869-7870	.	_

50-1	7871-7875	Next	_
50-2	7876-7877	,	_
50-3	7878-7881	all	_
50-4	7882-7890	subjects	_
50-5	7891-7895	were	_
50-6	7896-7906	instructed	_
50-7	7907-7909	to	_
50-8	7910-7915	relax	_
50-9	7916-7917	,	_
50-10	7918-7922	hold	_
50-11	7923-7928	still	_
50-12	7929-7930	,	_
50-13	7931-7934	and	_
50-14	7935-7941	fixate	_
50-15	7942-7945	the	_
50-16	7946-7954	fixation	_
50-17	7955-7960	point	_
50-18	7961-7962	(	_
50-19	7963-7968	cross	_
50-20	7969-7970	,	_
50-21	7971-7977	visual	_
50-22	7978-7983	angle	_
50-23	7984-7986	2°	_
50-24	7987-7988	)	_
50-25	7989-7991	at	_
50-26	7992-7995	the	_
50-27	7996-8002	center	_
50-28	8003-8005	of	_
50-29	8006-8009	the	_
50-30	8010-8016	screen	_
50-31	8017-8023	during	_
50-32	8024-8027	the	_
50-33	8028-8041	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
50-34	8042-8046	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
50-35	8047-8058	examination	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
50-36	8059-8060	.	_

51-1	8061-8064	140	_
51-2	8065-8075	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
51-3	8076-8082	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
51-4	8083-8085	at	_
51-5	8086-8089	the	_
51-6	8090-8094	same	_
51-7	8095-8104	locations	_
51-8	8105-8107	as	_
51-9	8108-8111	the	_
51-10	8112-8122	anatomical	_
51-11	8123-8129	slices	_
51-12	8130-8134	were	_
51-13	8135-8143	acquired	_
51-14	8144-8146	by	_
51-15	8147-8152	using	_
51-16	8153-8155	an	_
51-17	8156-8159	EPI	_
51-18	8160-8168	sequence	_
51-19	8169-8173	with	_
51-20	8174-8177	the	_
51-21	8178-8187	following	_
51-22	8188-8198	parameters	_
51-23	8199-8200	:	_
51-24	8201-8206	TR/TE	_
51-25	8207-8208	=	_
51-26	8209-8216	3000/30	_
51-27	8217-8219	ms	_
51-28	8220-8221	,	_
51-29	8222-8224	48	_
51-30	8225-8231	slices	_
51-31	8232-8233	,	_
51-32	8234-8236	64	_
51-33	8237-8238	×	_
51-34	8239-8241	64	_
51-35	8242-8248	matrix	_
51-36	8249-8250	,	_
51-37	8251-8254	80°	_
51-38	8255-8259	flip	_
51-39	8260-8265	angle	_
51-40	8266-8267	,	_
51-41	8268-8273	field	_
51-42	8274-8276	of	_
51-43	8277-8281	view	_
51-44	8282-8283	=	_
51-45	8284-8287	212	_
51-46	8288-8289	×	_
51-47	8290-8293	212	_
51-48	8294-8297	mm2	_
51-49	8298-8301	and	_
51-50	8302-8307	voxel	_
51-51	8308-8312	size	_
51-52	8313-8314	=	_
51-53	8315-8318	3.6	_
51-54	8319-8320	×	_
51-55	8321-8324	3.3	_
51-56	8325-8326	×	_
51-57	8327-8330	3.3	_
51-58	8331-8334	mm3	_
51-59	8335-8336	.	_

52-1	8337-8340	The	_
52-2	8341-8349	scanning	_
52-3	8350-8354	time	_
52-4	8355-8358	was	_
52-5	8359-8360	7	_
52-6	8361-8364	min	_
52-7	8365-8366	8	_
52-8	8367-8369	s.	_
52-9	8370-8377	Finally	_
52-10	8378-8379	,	_
52-11	8380-8383	DTI	_
52-12	8384-8387	was	_
52-13	8388-8397	performed	_
52-14	8398-8403	using	_
52-15	8404-8407	the	_
52-16	8408-8412	spin	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
52-17	8413-8417	echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
52-18	8418-8429	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
52-19	8430-8439	technique	_
52-20	8440-8441	(	_
52-21	8442-8447	TR/TE	_
52-22	8448-8449	=	_
52-23	8450-8456	14,100	_
52-24	8457-8460	/81	_
52-25	8461-8463	ms	_
52-26	8464-8465	,	_
52-27	8466-8469	90°	_
52-28	8470-8474	flip	_
52-29	8475-8480	angle	_
52-30	8481-8482	,	_
52-31	8483-8488	field	_
52-32	8489-8491	of	_
52-33	8492-8496	view	_
52-34	8497-8498	=	_
52-35	8499-8502	224	_
52-36	8503-8504	×	_
52-37	8505-8508	224	_
52-38	8509-8512	mm2	_
52-39	8513-8514	,	_
52-40	8515-8518	114	_
52-41	8519-8520	×	_
52-42	8521-8524	114	_
52-43	8525-8531	matrix	_
52-44	8532-8533	,	_
52-45	8534-8541	section	_
52-46	8542-8551	thickness	_
52-47	8552-8553	=	_
52-48	8554-8555	2	_
52-49	8556-8558	mm	_
52-50	8559-8563	with	_
52-51	8564-8566	no	_
52-52	8567-8570	gap	_
52-53	8571-8572	)	_
52-54	8573-8574	.	_

53-1	8575-8581	Images	_
53-2	8582-8586	were	_
53-3	8587-8595	obtained	_
53-4	8596-8600	with	_
53-5	8601-8605	both	_
53-6	8606-8618	30-direction	_
53-7	8619-8628	diffusion	_
53-8	8629-8637	encoding	_
53-9	8638-8639	(	_
53-10	8640-8641	b	_
53-11	8642-8643	=	_
53-12	8644-8648	1000	_
53-13	8649-8654	s/mm2	_
53-14	8655-8658	for	_
53-15	8659-8663	each	_
53-16	8664-8673	direction	_
53-17	8674-8675	)	_
53-18	8676-8679	and	_
53-19	8680-8682	no	_
53-20	8683-8692	diffusion	_
53-21	8693-8701	encoding	_
53-22	8702-8703	(	_
53-23	8704-8705	b	_
53-24	8706-8707	=	_
53-25	8708-8709	0	_
53-26	8710-8715	s/mm2	_
53-27	8716-8717	)	_
53-28	8718-8719	.	_

54-1	8720-8721	A	_
54-2	8722-8727	total	_
54-3	8728-8730	of	_
54-4	8731-8733	75	_
54-5	8734-8739	axial	_
54-6	8740-8747	section	_
54-7	8748-8754	images	_
54-8	8755-8759	were	_
54-9	8760-8768	obtained	_
54-10	8769-8770	,	_
54-11	8771-8779	covering	_
54-12	8780-8783	the	_
54-13	8784-8790	entire	_
54-14	8791-8799	cerebrum	_
54-15	8800-8801	.	_

55-1	8802-8805	The	_
55-2	8806-8814	scanning	_
55-3	8815-8819	time	_
55-4	8820-8823	was	_
55-5	8824-8825	8	_
55-6	8826-8829	min	_
55-7	8830-8831	1	_
55-8	8832-8834	s.	_
55-9	8835-8838	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
55-10	8839-8843	data	_
55-11	8844-8848	from	_
55-12	8849-8850	2	_
55-13	8851-8859	patients	_
55-14	8860-8864	were	_
55-15	8865-8873	excluded	_
55-16	8874-8878	from	_
55-17	8879-8882	the	_
55-18	8883-8891	analysis	_
55-19	8892-8899	because	_
55-20	8900-8902	of	_
55-21	8903-8906	the	_
55-22	8907-8916	excessive	_
55-23	8917-8923	motion	_
55-24	8924-8925	>	_
55-25	8926-8927	2	_
55-26	8928-8930	mm	_
55-27	8931-8938	maximum	_
55-28	8939-8951	displacement	_
55-29	8952-8954	in	_
55-30	8955-8956	x	_
55-31	8957-8958	,	_
55-32	8959-8960	y	_
55-33	8961-8963	or	_
55-34	8964-8965	z	_
55-35	8966-8969	and	_
55-36	8970-8971	>	_
55-37	8972-8975	1.0	_
55-38	8976-8982	degree	_
55-39	8983-8985	of	_
55-40	8986-8993	angular	_
55-41	8994-9000	motion	_
55-42	9001-9006	about	_
55-43	9007-9011	each	_
55-44	9012-9016	axis	_
55-45	9017-9018	.	_

56-1	9019-9023	FMRI	_
56-2	9024-9028	data	_
56-3	9029-9037	analysis	_
56-4	9038-9042	Data	_
56-5	9043-9047	were	_
56-6	9048-9056	analyzed	_
56-7	9057-9062	using	_
56-8	9063-9074	Statistical	_
56-9	9075-9085	Parametric	_
56-10	9086-9093	Mapping	_
56-11	9094-9095	(	_
56-12	9096-9100	SPM8	_
56-13	9101-9102	,	_
56-14	9103-9111	Wellcome	_
56-15	9112-9122	Department	_
56-16	9123-9125	of	_
56-17	9126-9133	Imaging	_
56-18	9134-9146	Neuroscience	_
56-19	9147-9148	,	_
56-20	9149-9158	Institute	_
56-21	9159-9161	of	_
56-22	9162-9171	Neurology	_
56-23	9172-9173	,	_
56-24	9174-9180	London	_
56-25	9181-9182	,	_
56-26	9183-9185	UK	_
56-27	9186-9187	;	_
56-28	9188-9192	http	_
56-29	9193-9194	:	_
56-30	9195-9223	//www.fil.ion.ucl.ac.uk/spm/	_
56-31	9224-9225	)	_
56-32	9226-9227	.	_

57-1	9228-9234	Images	_
57-2	9235-9239	were	_
57-3	9240-9249	corrected	_
57-4	9250-9253	for	_
57-5	9254-9259	slice	_
57-6	9260-9271	acquisition	_
57-7	9272-9276	time	_
57-8	9277-9283	within	_
57-9	9284-9288	each	_
57-10	9289-9295	volume	_
57-11	9296-9297	,	_
57-12	9298-9314	motion-corrected	_
57-13	9315-9319	with	_
57-14	9320-9331	realignment	_
57-15	9332-9334	to	_
57-16	9335-9338	the	_
57-17	9339-9344	first	_
57-18	9345-9351	volume	_
57-19	9352-9353	,	_
57-20	9354-9363	spatially	_
57-21	9364-9374	normalized	_
57-22	9375-9377	to	_
57-23	9378-9381	the	_
57-24	9382-9390	standard	_
57-25	9391-9399	Montreal	_
57-26	9400-9412	Neurological	_
57-27	9413-9422	Institute	_
57-28	9423-9424	(	_
57-29	9425-9428	MNI	_
57-30	9429-9430	)	_
57-31	9431-9434	EPI	_
57-32	9435-9443	template	_
57-33	9444-9445	,	_
57-34	9446-9449	and	_
57-35	9450-9459	spatially	_
57-36	9460-9468	smoothed	_
57-37	9469-9474	using	_
57-38	9475-9476	a	_
57-39	9477-9485	Gaussian	_
57-40	9486-9492	kernel	_
57-41	9493-9497	with	_
57-42	9498-9499	a	_
57-43	9500-9504	full	_
57-44	9505-9510	width	_
57-45	9511-9513	at	_
57-46	9514-9518	half	_
57-47	9519-9526	maximum	_
57-48	9527-9529	of	_
57-49	9530-9531	8	_
57-50	9532-9534	mm	_
57-51	9535-9536	.	_

58-1	9537-9540	For	_
58-2	9541-9545	each	_
58-3	9546-9557	participant	_
58-4	9558-9559	,	_
58-5	9560-9563	the	_
58-6	9564-9568	BOLD	_
58-7	9569-9578	responses	_
58-8	9579-9585	across	_
58-9	9586-9589	the	_
58-10	9590-9598	scanning	_
58-11	9599-9602	run	_
58-12	9603-9607	were	_
58-13	9608-9615	modeled	_
58-14	9616-9620	with	_
58-15	9621-9622	a	_
58-16	9623-9630	general	_
58-17	9631-9637	linear	_
58-18	9638-9643	model	_
58-19	9644-9645	.	_

59-1	9646-9649	The	_
59-2	9650-9655	model	_
59-3	9656-9664	included	_
59-4	9665-9668	the	_
59-5	9669-9678	following	_
59-6	9679-9689	regressors	_
59-7	9690-9692	of	_
59-8	9693-9701	interest	_
59-9	9702-9703	:	_
59-10	9704-9716	presentation	_
59-11	9717-9719	of	_
59-12	9720-9722	SW	_
59-13	9723-9727	task	_
59-14	9728-9731	cue	_
59-15	9732-9733	,	_
59-16	9734-9746	presentation	_
59-17	9747-9749	of	_
59-18	9750-9752	WS	_
59-19	9753-9757	task	_
59-20	9758-9761	cue	_
59-21	9762-9763	,	_
59-22	9764-9776	presentation	_
59-23	9777-9779	of	_
59-24	9780-9787	success	_
59-25	9788-9796	feedback	_
59-26	9797-9799	in	_
59-27	9800-9803	the	_
59-28	9804-9806	SW	_
59-29	9807-9811	task	_
59-30	9812-9813	,	_
59-31	9814-9826	presentation	_
59-32	9827-9829	of	_
59-33	9830-9837	failure	_
59-34	9838-9846	feedback	_
59-35	9847-9849	in	_
59-36	9850-9853	the	_
59-37	9854-9856	SW	_
59-38	9857-9861	task	_
59-39	9862-9863	.	_

60-1	9864-9867	The	_
60-2	9868-9874	motion	_
60-3	9875-9885	parameters	_
60-4	9886-9887	,	_
60-5	9888-9901	inappropriate	_
60-6	9902-9908	trials	_
60-7	9909-9914	which	_
60-8	9915-9927	participants	_
60-9	9928-9931	did	_
60-10	9932-9935	not	_
60-11	9936-9941	press	_
60-12	9942-9943	a	_
60-13	9944-9950	button	_
60-14	9951-9953	in	_
60-15	9954-9957	the	_
60-16	9958-9960	SW	_
60-17	9961-9965	task	_
60-18	9966-9968	or	_
60-19	9969-9974	press	_
60-20	9975-9976	a	_
60-21	9977-9983	button	_
60-22	9984-9990	before	_
60-23	9991-9992	a	_
60-24	9993-9995	SW	_
60-25	9996-10003	stopped	_
60-26	10004-10006	in	_
60-27	10007-10010	the	_
60-28	10011-10013	WS	_
60-29	10014-10018	task	_
60-30	10019-10023	were	_
60-31	10024-10028	also	_
60-32	10029-10037	included	_
60-33	10038-10040	as	_
60-34	10041-10051	regressors	_
60-35	10052-10054	of	_
60-36	10055-10057	no	_
60-37	10058-10066	interest	_
60-38	10067-10068	.	_

61-1	10069-10072	The	_
61-2	10073-10083	regressors	_
61-3	10084-10085	(	_
61-4	10086-10092	except	_
61-5	10093-10096	for	_
61-6	10097-10100	the	_
61-7	10101-10107	motion	_
61-8	10108-10118	parameters	_
61-9	10119-10120	)	_
61-10	10121-10125	were	_
61-11	10126-10136	calculated	_
61-12	10137-10142	using	_
61-13	10143-10144	a	_
61-14	10145-10151	boxcar	_
61-15	10152-10160	function	_
61-16	10161-10170	convolved	_
61-17	10171-10175	with	_
61-18	10176-10177	a	_
61-19	10178-10198	hemodynamic-response	_
61-20	10199-10207	function	_
61-21	10208-10209	.	_

62-1	10210-10213	The	_
62-2	10214-10223	estimates	_
62-3	10224-10228	were	_
62-4	10229-10238	corrected	_
62-5	10239-10242	for	_
62-6	10243-10251	temporal	_
62-7	10252-10267	autocorrelation	_
62-8	10268-10270	by	_
62-9	10271-10276	using	_
62-10	10277-10278	a	_
62-11	10279-10290	first-order	_
62-12	10291-10305	autoregressive	_
62-13	10306-10311	model	_
62-14	10312-10313	.	_

63-1	10314-10316	To	_
63-2	10317-10328	investigate	_
63-3	10329-10332	cue	_
63-4	10333-10340	effects	_
63-5	10341-10344	and	_
63-6	10345-10348	the	_
63-7	10349-10357	feedback	_
63-8	10358-10365	effects	_
63-9	10366-10367	,	_
63-10	10368-10371	our	_
63-11	10372-10379	primary	_
63-12	10380-10385	focus	_
63-13	10386-10388	of	_
63-14	10389-10397	interest	_
63-15	10398-10399	,	_
63-16	10400-10403	two	_
63-17	10404-10412	contrast	_
63-18	10413-10419	values	_
63-19	10420-10424	were	_
63-20	10425-10435	calculated	_
63-21	10436-10437	:	_
63-22	10438-10439	(	_
63-23	10440-10441	i	_
63-24	10442-10443	)	_
63-25	10444-10452	contrast	_
63-26	10453-10460	between	_
63-27	10461-10463	SW	_
63-28	10464-10468	task	_
63-29	10469-10472	cue	_
63-30	10473-10476	and	_
63-31	10477-10479	WS	_
63-32	10480-10484	task	_
63-33	10485-10488	cue	_
63-34	10489-10496	effects	_
63-35	10497-10498	(	_
63-36	10499-10503	i.e.	_
63-37	10504-10505	,	_
63-38	10506-10508	SW	_
63-39	10509-10514	minus	_
63-40	10515-10517	WS	_
63-41	10518-10519	)	_
63-42	10520-10521	,	_
63-43	10522-10525	and	_
63-44	10526-10527	(	_
63-45	10528-10530	ii	_
63-46	10531-10532	)	_
63-47	10533-10541	contrast	_
63-48	10542-10549	between	_
63-49	10550-10557	success	_
63-50	10558-10566	feedback	_
63-51	10567-10570	and	_
63-52	10571-10578	failure	_
63-53	10579-10587	feedback	_
63-54	10588-10595	effects	_
63-55	10596-10597	(	_
63-56	10598-10602	i.e.	_
63-57	10603-10604	,	_
63-58	10605-10612	success	_
63-59	10613-10618	minus	_
63-60	10619-10626	failure	_
63-61	10627-10628	)	_
63-62	10629-10630	.	_

64-1	10631-10633	In	_
64-2	10634-10640	region	_
64-3	10641-10643	of	_
64-4	10644-10652	interest	_
64-5	10653-10654	(	_
64-6	10655-10658	ROI	_
64-7	10659-10660	)	_
64-8	10661-10669	analysis	_
64-9	10670-10671	,	_
64-10	10672-10674	we	_
64-11	10675-10685	calculated	_
64-12	10686-10689	the	_
64-13	10690-10695	peaks	_
64-14	10696-10698	of	_
64-15	10699-10707	clusters	_
64-16	10708-10712	that	_
64-17	10713-10719	showed	_
64-18	10720-10731	significant	_
64-19	10732-10742	activation	_
64-20	10743-10749	during	_
64-21	10750-10753	the	_
64-22	10754-10757	cue	_
64-23	10758-10764	period	_
64-24	10765-10766	(	_
64-25	10767-10772	SW-WS	_
64-26	10773-10774	)	_
64-27	10775-10778	and	_
64-28	10779-10782	the	_
64-29	10783-10791	feedback	_
64-30	10792-10798	period	_
64-31	10799-10800	(	_
64-32	10801-10816	Success-Failure	_
64-33	10817-10818	)	_
64-34	10819-10820	.	_

65-1	10821-10824	For	_
65-2	10825-10828	the	_
65-3	10829-10837	analysis	_
65-4	10838-10840	of	_
65-5	10841-10844	the	_
65-6	10845-10849	LPFC	_
65-7	10850-10853	and	_
65-8	10854-10862	striatum	_
65-9	10863-10864	,	_
65-10	10865-10869	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
65-11	10870-10874	data	_
65-12	10875-10879	were	_
65-13	10880-10886	masked	_
65-14	10887-10899	anatomically	_
65-15	10900-10905	using	_
65-16	10906-10909	the	_
65-17	10910-10919	Automated	_
65-18	10920-10930	Anatomical	_
65-19	10931-10939	Labeling	_
65-20	10940-10945	atlas	_
65-21	10946-10948	of	_
65-22	10949-10952	the	_
65-23	10953-10956	WFU	_
65-24	10957-10958	(	_
65-25	10959-10963	Wake	_
65-26	10964-10970	Forest	_
65-27	10971-10981	University	_
65-28	10982-10983	)	_
65-29	10984-10993	Pickatlas	_
65-30	10994-11001	toolbox	_
65-31	11002-11003	.	_

66-1	11004-11007	The	_
66-2	11008-11012	mask	_
66-3	11013-11016	for	_
66-4	11017-11020	the	_
66-5	11021-11025	LPFC	_
66-6	11026-11035	consisted	_
66-7	11036-11038	of	_
66-8	11039-11043	area	_
66-9	11044-11046	46	_
66-10	11047-11048	,	_
66-11	11049-11052	and	_
66-12	11053-11056	the	_
66-13	11057-11061	mask	_
66-14	11062-11065	for	_
66-15	11066-11069	the	_
66-16	11070-11078	striatum	_
66-17	11079-11088	consisted	_
66-18	11089-11091	of	_
66-19	11092-11095	the	_
66-20	11096-11103	caudate	_
66-21	11104-11107	and	_
66-22	11108-11115	putamen	_
66-23	11116-11117	.	_

67-1	11118-11122	Then	_
67-2	11123-11124	,	_
67-3	11125-11128	the	_
67-4	11129-11133	peak	_
67-5	11134-11144	activation	_
67-6	11145-11151	voxels	_
67-7	11152-11154	in	_
67-8	11155-11158	the	_
67-9	11159-11163	LPFC	_
67-10	11164-11167	and	_
67-11	11168-11171	the	_
67-12	11172-11180	striatum	_
67-13	11181-11185	were	_
67-14	11186-11194	selected	_
67-15	11195-11196	(	_
67-16	11197-11200	FWE	_
67-17	11201-11202	p	_
67-18	11203-11204	<	_
67-19	11205-11209	0.05	_
67-20	11210-11211	,	_
67-21	11212-11222	one-sample	_
67-22	11223-11229	t-test	_
67-23	11230-11231	)	_
67-24	11232-11233	.	_

68-1	11234-11241	However	_
68-2	11242-11243	,	_
68-3	11244-11247	for	_
68-4	11248-11251	the	_
68-5	11252-11260	analysis	_
68-6	11261-11263	of	_
68-7	11264-11267	the	_
68-8	11268-11271	cue	_
68-9	11272-11282	activation	_
68-10	11283-11285	in	_
68-11	11286-11289	the	_
68-12	11290-11298	striatum	_
68-13	11299-11300	,	_
68-14	11301-11303	we	_
68-15	11304-11311	adopted	_
68-16	11312-11315	the	_
68-17	11316-11320	beta	_
68-18	11321-11327	values	_
68-19	11328-11330	of	_
68-20	11331-11335	peak	_
68-21	11336-11342	voxels	_
68-22	11343-11348	which	_
68-23	11349-11355	showed	_
68-24	11356-11357	a	_
68-25	11358-11369	significant	_
68-26	11370-11380	difference	_
68-27	11381-11388	between	_
68-28	11389-11392	SCZ	_
68-29	11393-11396	and	_
68-30	11397-11399	HC	_
68-31	11400-11401	(	_
68-32	11402-11403	p	_
68-33	11404-11405	<	_
68-34	11406-11410	0.05	_
68-35	11411-11414	FWE	_
68-36	11415-11422	cluster	_
68-37	11423-11433	correction	_
68-38	11434-11435	,	_
68-39	11436-11446	two-sample	_
68-40	11447-11453	t-test	_
68-41	11454-11455	)	_
68-42	11456-11457	.	_

69-1	11458-11460	We	_
69-2	11461-11468	created	_
69-3	11469-11474	small	_
69-4	11475-11479	ROIs	_
69-5	11480-11481	(	_
69-6	11482-11483	6	_
69-7	11484-11486	mm	_
69-8	11487-11494	spheres	_
69-9	11495-11496	)	_
69-10	11497-11499	at	_
69-11	11500-11503	the	_
69-12	11504-11509	peaks	_
69-13	11510-11512	of	_
69-14	11513-11523	activation	_
69-15	11524-11532	clusters	_
69-16	11533-11534	.	_

70-1	11535-11545	Functional	_
70-2	11546-11558	connectivity	_
70-3	11559-11567	analyses	_
70-4	11568-11570	by	_
70-5	11571-11584	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
70-6	11585-11589	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
70-7	11590-11593	The	_
70-8	11594-11600	target	_
70-9	11601-11605	ROIs	_
70-10	11606-11615	consisted	_
70-11	11616-11618	of	_
70-12	11619-11623	6-mm	_
70-13	11624-11630	radius	_
70-14	11631-11638	spheres	_
70-15	11639-11647	centered	_
70-16	11648-11650	on	_
70-17	11651-11654	the	_
70-18	11655-11659	LPFC	_
70-19	11660-11672	coordination	_
70-20	11673-11681	obtained	_
70-21	11682-11684	by	_
70-22	11685-11689	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
70-23	11690-11694	data	_
70-24	11695-11701	during	_
70-25	11702-11705	the	_
70-26	11706-11710	task	_
70-27	11711-11722	performance	_
70-28	11723-11726	and	_
70-29	11727-11729	of	_
70-30	11730-11733	the	_
70-31	11734-11742	striatum	_
70-32	11743-11748	cited	_
70-33	11749-11753	from	_
70-34	11754-11757	the	_
70-35	11758-11761	AAL	_
70-36	11762-11763	(	_
70-37	11764-11773	Automated	_
70-38	11774-11784	Anatomical	_
70-39	11785-11793	Labeling	_
70-40	11794-11795	)	_
70-41	11796-11804	template	_
70-42	11805-11806	.	_

71-1	11807-11817	Functional	_
71-2	11818-11830	connectivity	_
71-3	11831-11833	of	_
71-4	11834-11840	target	_
71-5	11841-11845	ROIs	_
71-6	11846-11849	was	_
71-7	11850-11858	acquired	_
71-8	11859-11861	as	_
71-9	11862-11869	follows	_
71-10	11870-11872	by	_
71-11	11873-11878	using	_
71-12	11879-11883	CONN	_
71-13	11884-11891	toolbox	_
71-14	11892-11899	version	_
71-15	11900-11904	13.b	_
71-16	11905-11906	;	_
71-17	11907-11909	at	_
71-18	11910-11915	first	_
71-19	11916-11917	,	_
71-20	11918-11919	a	_
71-21	11920-11926	signal	_
71-22	11927-11938	time-series	_
71-23	11939-11945	within	_
71-24	11946-11949	the	_
71-25	11950-11955	voxel	_
71-26	11956-11959	was	_
71-27	11960-11969	extracted	_
71-28	11970-11974	from	_
71-29	11975-11979	each	_
71-30	11980-11983	ROI	_
71-31	11984-11985	.	_

72-1	11986-11989	For	_
72-2	11990-11993	the	_
72-3	11994-12001	removal	_
72-4	12002-12004	of	_
72-5	12005-12012	signals	_
72-6	12013-12015	of	_
72-7	12016-12018	no	_
72-8	12019-12027	interest	_
72-9	12028-12029	,	_
72-10	12030-12037	signals	_
72-11	12038-12048	correlated	_
72-12	12049-12053	with	_
72-13	12054-12055	6	_
72-14	12056-12062	motion	_
72-15	12063-12073	parameters	_
72-16	12074-12078	from	_
72-17	12079-12082	the	_
72-18	12083-12094	realignment	_
72-19	12095-12104	procedure	_
72-20	12105-12108	and	_
72-21	12109-12116	signals	_
72-22	12117-12124	derived	_
72-23	12125-12129	from	_
72-24	12130-12133	the	_
72-25	12134-12140	entire	_
72-26	12141-12146	White	_
72-27	12147-12153	matter	_
72-28	12154-12158	mask	_
72-29	12159-12162	and	_
72-30	12163-12166	CSF	_
72-31	12167-12171	mask	_
72-32	12172-12176	were	_
72-33	12177-12186	regressed	_
72-34	12187-12190	out	_
72-35	12191-12193	in	_
72-36	12194-12198	each	_
72-37	12199-12210	participant	_
72-38	12211-12212	,	_
72-39	12213-12215	by	_
72-40	12216-12221	using	_
72-41	12222-12223	a	_
72-42	12224-12231	general	_
72-43	12232-12238	linear	_
72-44	12239-12244	model	_
72-45	12245-12246	(	_
72-46	12247-12250	GLM	_
72-47	12251-12252	)	_
72-48	12253-12259	-based	_
72-49	12260-12268	multiple	_
72-50	12269-12279	regression	_
72-51	12280-12281	.	_

73-1	12282-12285	And	_
73-2	12286-12290	then	_
73-3	12291-12297	linear	_
73-4	12298-12308	detrending	_
73-5	12309-12312	and	_
73-6	12313-12322	despiking	_
73-7	12323-12326	was	_
73-8	12327-12334	applied	_
73-9	12335-12337	to	_
73-10	12338-12345	yielded	_
73-11	12346-12353	signals	_
73-12	12354-12356	to	_
73-13	12357-12365	diminish	_
73-14	12366-12369	the	_
73-15	12370-12376	effect	_
73-16	12377-12379	of	_
73-17	12380-12384	head	_
73-18	12385-12391	motion	_
73-19	12392-12393	.	_

74-1	12394-12399	After	_
74-2	12400-12404	that	_
74-3	12405-12406	,	_
74-4	12407-12423	confound-removed	_
74-5	12424-12428	time	_
74-6	12429-12435	course	_
74-7	12436-12442	within	_
74-8	12443-12446	the	_
74-9	12447-12452	voxel	_
74-10	12453-12456	was	_
74-11	12457-12465	averaged	_
74-12	12466-12472	across	_
74-13	12473-12476	the	_
74-14	12477-12482	voxel	_
74-15	12483-12485	of	_
74-16	12486-12490	ROIs	_
74-17	12491-12492	.	_

75-1	12493-12500	Finally	_
75-2	12501-12502	,	_
75-3	12503-12506	all	_
75-4	12507-12509	of	_
75-5	12510-12513	the	_
75-6	12514-12530	confound-removed	_
75-7	12531-12535	time	_
75-8	12536-12542	course	_
75-9	12543-12547	data	_
75-10	12548-12557	underwent	_
75-11	12558-12559	a	_
75-12	12560-12569	band-pass	_
75-13	12570-12579	filtering	_
75-14	12580-12582	of	_
75-15	12583-12591	0.01–0.1	_
75-16	12592-12594	Hz	_
75-17	12595-12596	.	_

76-1	12597-12600	And	_
76-2	12601-12605	then	_
76-3	12606-12607	,	_
76-4	12608-12611	the	_
76-5	12612-12623	correlation	_
76-6	12624-12635	coefficient	_
76-7	12636-12638	of	_
76-8	12639-12643	BOLD	_
76-9	12644-12650	signal	_
76-10	12651-12662	time-course	_
76-11	12663-12666	was	_
76-12	12667-12675	computed	_
76-13	12676-12683	between	_
76-14	12684-12690	target	_
76-15	12691-12695	ROIs	_
76-16	12696-12697	,	_
76-17	12698-12701	and	_
76-18	12702-12708	Fisher	_
76-19	12709-12711	's	_
76-20	12712-12723	z-transform	_
76-21	12724-12727	was	_
76-22	12728-12735	applied	_
76-23	12736-12739	for	_
76-24	12740-12744	each	_
76-25	12745-12756	coefficient	_
76-26	12757-12758	,	_
76-27	12759-12767	yielding	_
76-28	12768-12776	strength	_
76-29	12777-12779	of	_
76-30	12780-12790	functional	_
76-31	12791-12803	connectivity	_
76-32	12804-12806	in	_
76-33	12807-12811	each	_
76-34	12812-12819	subject	_
76-35	12820-12821	.	_

77-1	12822-12833	Calculation	_
77-2	12834-12836	of	_
77-3	12837-12840	the	_
77-4	12841-12843	FA	_
77-5	12844-12849	value	_
77-6	12850-12852	by	_
77-7	12853-12866	probabilistic	_
77-8	12867-12879	tractography	_
77-9	12880-12884	Each	_
77-10	12885-12892	subject	_
77-11	12893-12895	's	_
77-12	12896-12909	3DT1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
77-13	12910-12916	images	_
77-14	12917-12921	were	_
77-15	12922-12927	first	_
77-16	12928-12936	linearly	_
77-17	12937-12947	registered	_
77-18	12948-12950	to	_
77-19	12951-12957	MNI152	_
77-20	12958-12966	standard	_
77-21	12967-12972	space	_
77-22	12973-12978	using	_
77-23	12979-12982	the	_
77-24	12983-12988	FLIRT	_
77-25	12989-12995	linear	_
77-26	12996-13008	registration	_
77-27	13009-13013	tool	_
77-28	13014-13017	and	_
77-29	13018-13019	a	_
77-30	13020-13040	12-degree-of-freedom	_
77-31	13041-13047	affine	_
77-32	13048-13062	transformation	_
77-33	13063-13064	(	_
77-34	13065-13069	part	_
77-35	13070-13072	of	_
77-36	13073-13076	FSL	_
77-37	13077-13078	,	_
77-38	13079-13083	http	_
77-39	13084-13085	:	_
77-40	13086-13119	//fsl.fmrib.ox.ac.uk/fsl/fslwiki/	_
77-41	13120-13121	)	_
77-42	13122-13123	.	_

78-1	13124-13127	The	_
78-2	13128-13136	linearly	_
78-3	13137-13148	transformed	_
78-4	13149-13162	3DT1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
78-5	13163-13169	images	_
78-6	13170-13174	were	_
78-7	13175-13179	then	_
78-8	13180-13184	used	_
78-9	13185-13187	as	_
78-10	13188-13191	the	_
78-11	13192-13197	input	_
78-12	13198-13200	to	_
78-13	13201-13212	nonlinearly	_
78-14	13213-13221	register	_
78-15	13222-13226	each	_
78-16	13227-13234	subject	_
78-17	13235-13237	's	_
78-18	13238-13243	image	_
78-19	13244-13248	into	_
78-20	13249-13255	MNI152	_
78-21	13256-13264	standard	_
78-22	13265-13270	space	_
78-23	13271-13276	using	_
78-24	13277-13280	FSL	_
78-25	13281-13283	's	_
78-26	13284-13289	FNIRT	_
78-27	13290-13299	nonlinear	_
78-28	13300-13312	registration	_
78-29	13313-13317	tool	_
78-30	13318-13319	.	_

79-1	13320-13323	All	_
79-2	13324-13334	registered	_
79-3	13335-13341	images	_
79-4	13342-13346	were	_
79-5	13347-13355	visually	_
79-6	13356-13365	inspected	_
79-7	13366-13369	for	_
79-8	13370-13378	accurate	_
79-9	13379-13391	registration	_
79-10	13392-13393	.	_

80-1	13394-13397	The	_
80-2	13398-13406	striatum	_
80-3	13407-13411	seed	_
80-4	13412-13418	region	_
80-5	13419-13422	for	_
80-6	13423-13436	probabilistic	_
80-7	13437-13449	tractography	_
80-8	13450-13453	was	_
80-9	13454-13459	taken	_
80-10	13460-13464	from	_
80-11	13465-13468	the	_
80-12	13469-13472	AAL	_
80-13	13473-13481	template	_
80-14	13482-13483	,	_
80-15	13484-13487	and	_
80-16	13488-13491	the	_
80-17	13492-13496	LPFC	_
80-18	13497-13503	target	_
80-19	13504-13510	region	_
80-20	13511-13514	for	_
80-21	13515-13528	probabilistic	_
80-22	13529-13541	tractography	_
80-23	13542-13545	was	_
80-24	13546-13551	taken	_
80-25	13552-13556	from	_
80-26	13557-13561	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
80-27	13562-13566	data	_
80-28	13567-13575	obtained	_
80-29	13576-13582	during	_
80-30	13583-13586	the	_
80-31	13587-13591	task	_
80-32	13592-13603	performance	_
80-33	13604-13605	.	_

81-1	13606-13608	An	_
81-2	13609-13616	inverse	_
81-3	13617-13631	transformation	_
81-4	13632-13635	was	_
81-5	13636-13640	used	_
81-6	13641-13643	to	_
81-7	13644-13651	convert	_
81-8	13652-13657	these	_
81-9	13658-13662	seed	_
81-10	13663-13666	and	_
81-11	13667-13673	target	_
81-12	13674-13678	ROIs	_
81-13	13679-13681	in	_
81-14	13682-13688	MNI152	_
81-15	13689-13697	standard	_
81-16	13698-13703	space	_
81-17	13704-13708	back	_
81-18	13709-13711	to	_
81-19	13712-13716	each	_
81-20	13717-13724	subject	_
81-21	13725-13727	's	_
81-22	13728-13734	native	_
81-23	13735-13740	space	_
81-24	13741-13742	.	_

82-1	13743-13746	The	_
82-2	13747-13750	raw	_
82-3	13751-13754	DTI	_
82-4	13755-13759	data	_
82-5	13760-13764	were	_
82-6	13765-13774	corrected	_
82-7	13775-13778	for	_
82-8	13779-13787	movement	_
82-9	13788-13791	and	_
82-10	13792-13795	for	_
82-11	13796-13800	eddy	_
82-12	13801-13808	current	_
82-13	13809-13820	distortions	_
82-14	13821-13826	using	_
82-15	13827-13830	the	_
82-16	13831-13836	FMRIB	_
82-17	13837-13846	Diffusion	_
82-18	13847-13854	Toolbox	_
82-19	13855-13856	(	_
82-20	13857-13861	part	_
82-21	13862-13864	of	_
82-22	13865-13868	FSL	_
82-23	13869-13870	)	_
82-24	13871-13872	.	_

83-1	13873-13876	The	_
83-2	13877-13890	probabilistic	_
83-3	13891-13903	tractography	_
83-4	13904-13907	was	_
83-5	13908-13917	performed	_
83-6	13918-13925	between	_
83-7	13926-13927	a	_
83-8	13928-13932	seed	_
83-9	13933-13936	ROI	_
83-10	13937-13938	(	_
83-11	13939-13942	the	_
83-12	13943-13951	striatum	_
83-13	13952-13953	)	_
83-14	13954-13957	and	_
83-15	13958-13959	a	_
83-16	13960-13966	target	_
83-17	13967-13970	ROI	_
83-18	13971-13972	(	_
83-19	13973-13976	the	_
83-20	13977-13981	LPFC	_
83-21	13982-13983	)	_
83-22	13984-13986	of	_
83-23	13987-13990	the	_
83-24	13991-14001	individual	_
83-25	14002-14008	brains	_
83-26	14009-14011	in	_
83-27	14012-14018	native	_
83-28	14019-14024	space	_
83-29	14025-14027	by	_
83-30	14028-14036	sampling	_
83-31	14037-14041	5000	_
83-32	14042-14052	streamline	_
83-33	14053-14059	fibers	_
83-34	14060-14061	.	_

84-1	14062-14066	Only	_
84-2	14067-14070	the	_
84-3	14071-14074	top	_
84-4	14075-14082	scoring	_
84-5	14083-14085	10	_
84-6	14086-14087	%	_
84-7	14088-14090	of	_
84-8	14091-14099	pathways	_
84-9	14100-14104	were	_
84-10	14105-14113	retained	_
84-11	14114-14115	;	_
84-12	14116-14121	these	_
84-13	14122-14130	pathways	_
84-14	14131-14135	were	_
84-15	14136-14140	then	_
84-16	14141-14151	considered	_
84-17	14152-14155	the	_
84-18	14156-14160	most	_
84-19	14161-14167	likely	_
84-20	14168-14176	pathways	_
84-21	14177-14187	connecting	_
84-22	14188-14191	the	_
84-23	14192-14196	pair	_
84-24	14197-14199	of	_
84-25	14200-14207	regions	_
84-26	14208-14209	.	_

85-1	14210-14213	The	_
85-2	14214-14227	probabilistic	_
85-3	14228-14240	tractography	_
85-4	14241-14244	was	_
85-5	14245-14253	visually	_
85-6	14254-14262	examined	_
85-7	14263-14266	for	_
85-8	14267-14271	each	_
85-9	14272-14279	subject	_
85-10	14280-14282	to	_
85-11	14283-14289	verify	_
85-12	14290-14293	the	_
85-13	14294-14304	trajectory	_
85-14	14305-14308	and	_
85-15	14309-14311	to	_
85-16	14312-14317	check	_
85-17	14318-14321	for	_
85-18	14322-14336	false-positive	_
85-19	14337-14348	streamlines	_
85-20	14349-14350	.	_

86-1	14351-14361	Fractional	_
86-2	14362-14372	anisotropy	_
86-3	14373-14374	(	_
86-4	14375-14377	FA	_
86-5	14378-14379	)	_
86-6	14380-14383	was	_
86-7	14384-14394	calculated	_
86-8	14395-14397	as	_
86-9	14398-14401	the	_
86-10	14402-14406	mean	_
86-11	14407-14412	value	_
86-12	14413-14419	within	_
86-13	14420-14424	each	_
86-14	14425-14430	tract	_
86-15	14431-14436	using	_
86-16	14437-14440	the	_
86-17	14441-14449	fslstats	_
86-18	14450-14457	command	_
86-19	14458-14462	line	_
86-20	14463-14467	tool	_
86-21	14468-14469	(	_
86-22	14470-14474	part	_
86-23	14475-14477	of	_
86-24	14478-14481	FSL	_
86-25	14482-14483	)	_
86-26	14484-14485	.	_

87-1	14486-14490	Path	_
87-2	14491-14499	analysis	_
87-3	14500-14502	In	_
87-4	14503-14506	the	_
87-5	14507-14511	path	_
87-6	14512-14520	analysis	_
87-7	14521-14522	,	_
87-8	14523-14533	structural	_
87-9	14534-14542	equation	_
87-10	14543-14551	modeling	_
87-11	14552-14553	(	_
87-12	14554-14557	SEM	_
87-13	14558-14559	)	_
87-14	14560-14563	was	_
87-15	14564-14568	used	_
87-16	14569-14571	to	_
87-17	14572-14578	assess	_
87-18	14579-14582	the	_
87-19	14583-14592	relations	_
87-20	14593-14598	among	_
87-21	14599-14602	the	_
87-22	14603-14612	variables	_
87-23	14613-14622	including	_
87-24	14623-14629	neural	_
87-25	14630-14638	activity	_
87-26	14639-14642	and	_
87-27	14643-14646	IMI	_
87-28	14647-14650	and	_
87-29	14651-14654	the	_
87-30	14655-14665	behavioral	_
87-31	14666-14670	data	_
87-32	14671-14679	obtained	_
87-33	14680-14682	in	_
87-34	14683-14687	this	_
87-35	14688-14693	study	_
87-36	14694-14695	.	_

88-1	14696-14698	We	_
88-2	14699-14707	selected	_
88-3	14708-14726	maximum-likelihood	_
88-4	14727-14731	with	_
88-5	14732-14738	robust	_
88-6	14739-14747	standard	_
88-7	14748-14753	error	_
88-8	14754-14755	(	_
88-9	14756-14759	MLR	_
88-10	14760-14761	)	_
88-11	14762-14764	as	_
88-12	14765-14768	the	_
88-13	14769-14775	method	_
88-14	14776-14778	of	_
88-15	14779-14789	estimation	_
88-16	14790-14791	.	_

89-1	14792-14797	These	_
89-2	14798-14806	analyses	_
89-3	14807-14811	were	_
89-4	14812-14821	conducted	_
89-5	14822-14824	in	_
89-6	14825-14831	M-plus	_
89-7	14832-14838	v.7.31	_
89-8	14839-14840	.	_

90-1	14841-14843	To	_
90-2	14844-14855	investigate	_
90-3	14856-14859	the	_
90-4	14860-14873	translational	_
90-5	14874-14881	process	_
90-6	14882-14884	of	_
90-7	14885-14897	motivational	_
90-8	14898-14909	information	_
90-9	14910-14918	elicited	_
90-10	14919-14921	in	_
90-11	14922-14925	the	_
90-12	14926-14934	striatum	_
90-13	14935-14939	into	_
90-14	14940-14946	action	_
90-15	14947-14952	plans	_
90-16	14953-14961	produced	_
90-17	14962-14964	in	_
90-18	14965-14968	the	_
90-19	14969-14973	LPFC	_
90-20	14974-14975	,	_
90-21	14976-14978	we	_
90-22	14979-14990	prioritized	_
90-23	14991-14994	the	_
90-24	14995-14999	flow	_
90-25	15000-15002	of	_
90-26	15003-15014	information	_
90-27	15015-15019	from	_
90-28	15020-15023	the	_
90-29	15024-15032	striatum	_
90-30	15033-15035	to	_
90-31	15036-15040	LPFC	_
90-32	15041-15043	in	_
90-33	15044-15047	the	_
90-34	15048-15052	path	_
90-35	15053-15061	analysis	_
90-36	15062-15063	.	_

91-1	15064-15071	However	_
91-2	15072-15073	,	_
91-3	15074-15076	we	_
91-4	15077-15081	also	_
91-5	15082-15090	examined	_
91-6	15091-15094	the	_
91-7	15095-15103	opposite	_
91-8	15104-15108	flow	_
91-9	15109-15111	of	_
91-10	15112-15123	information	_
91-11	15124-15128	from	_
91-12	15129-15133	LPFC	_
91-13	15134-15136	to	_
91-14	15137-15140	the	_
91-15	15141-15149	striatum	_
91-16	15150-15151	.	_

92-1	15152-15157	Using	_
92-2	15158-15162	four	_
92-3	15163-15171	observed	_
92-4	15172-15181	variables	_
92-5	15182-15183	,	_
92-6	15184-15186	we	_
92-7	15187-15195	analyzed	_
92-8	15196-15198	an	_
92-9	15199-15212	unconstrained	_
92-10	15213-15218	model	_
92-11	15219-15222	and	_
92-12	15223-15231	assessed	_
92-13	15232-15235	the	_
92-14	15236-15241	model	_
92-15	15242-15243	’	_
92-16	15244-15247	fit	_
92-17	15248-15252	with	_
92-18	15253-15256	SCZ	_
92-19	15257-15260	and	_
92-20	15261-15263	HC	_
92-21	15264-15268	data	_
92-22	15269-15270	,	_
92-23	15271-15283	respectively	_
92-24	15284-15285	.	_

93-1	15286-15289	Fit	_
93-2	15290-15293	was	_
93-3	15294-15302	assessed	_
93-4	15303-15308	using	_
93-5	15309-15312	the	_
93-6	15313-15315	χ2	_
93-7	15316-15324	goodness	_
93-8	15325-15327	of	_
93-9	15328-15331	fit	_
93-10	15332-15337	index	_
93-11	15338-15339	,	_
93-12	15340-15346	Akaike	_
93-13	15347-15349	's	_
93-14	15350-15361	information	_
93-15	15362-15370	criteria	_
93-16	15371-15372	(	_
93-17	15373-15376	AIC	_
93-18	15377-15378	)	_
93-19	15379-15380	,	_
93-20	15381-15389	Bayesian	_
93-21	15390-15401	information	_
93-22	15402-15410	criteria	_
93-23	15411-15412	(	_
93-24	15413-15416	BIC	_
93-25	15417-15418	)	_
93-26	15419-15420	,	_
93-27	15421-15424	the	_
93-28	15425-15436	comparative	_
93-29	15437-15440	fit	_
93-30	15441-15446	index	_
93-31	15447-15448	(	_
93-32	15449-15452	CFI	_
93-33	15453-15454	)	_
93-34	15455-15456	,	_
93-35	15457-15460	and	_
93-36	15461-15464	the	_
93-37	15465-15477	standardized	_
93-38	15478-15482	root	_
93-39	15483-15487	mean	_
93-40	15488-15494	square	_
93-41	15495-15503	residual	_
93-42	15504-15505	(	_
93-43	15506-15510	SRMR	_
93-44	15511-15512	)	_
93-45	15513-15514	.	_

94-1	15515-15523	Criteria	_
94-2	15524-15527	for	_
94-3	15528-15537	assessing	_
94-4	15538-15543	model	_
94-5	15544-15547	fit	_
94-6	15548-15556	included	_
94-7	15557-15558	:	_
94-8	15559-15560	p	_
94-9	15561-15566	value	_
94-10	15567-15569	of	_
94-11	15570-15572	χ2	_
94-12	15573-15574	(	_
94-13	15575-15577	df	_
94-14	15578-15579	)	_
94-15	15580-15581	≥	_
94-16	15582-15586	0.05	_
94-17	15587-15588	;	_
94-18	15589-15592	CFI	_
94-19	15593-15594	≥	_
94-20	15595-15599	0.95	_
94-21	15600-15601	;	_
94-22	15602-15605	and	_
94-23	15606-15610	SRMR	_
94-24	15611-15612	≤	_
94-25	15613-15616	0.1	_
94-26	15617-15618	.	_

95-1	15619-15621	If	_
95-2	15622-15625	the	_
95-3	15626-15635	estimates	_
95-4	15636-15638	of	_
95-5	15639-15642	the	_
95-6	15643-15648	model	_
95-7	15649-15653	were	_
95-8	15654-15663	different	_
95-9	15664-15666	in	_
95-10	15667-15670	SCZ	_
95-11	15671-15674	and	_
95-12	15675-15677	HC	_
95-13	15678-15679	,	_
95-14	15680-15682	we	_
95-15	15683-15692	performed	_
95-16	15693-15707	multiple-group	_
95-17	15708-15718	structural	_
95-18	15719-15727	equation	_
95-19	15728-15736	modeling	_
95-20	15737-15738	(	_
95-21	15739-15744	MGSEM	_
95-22	15745-15746	)	_
95-23	15747-15749	to	_
95-24	15750-15757	examine	_
95-25	15758-15761	the	_
95-26	15762-15770	validity	_
95-27	15771-15772	.	_

96-1	15773-15785	Specifically	_
96-2	15786-15787	,	_
96-3	15788-15790	we	_
96-4	15791-15799	compared	_
96-5	15800-15803	the	_
96-6	15804-15807	fit	_
96-7	15808-15815	between	_
96-8	15816-15819	two	_
96-9	15820-15826	models	_
96-10	15827-15829	by	_
96-11	15830-15839	examining	_
96-12	15840-15843	the	_
96-13	15844-15850	change	_
96-14	15851-15853	on	_
96-15	15854-15857	the	_
96-16	15858-15863	model	_
96-17	15864-15867	fit	_
96-18	15868-15875	indices	_
96-19	15876-15877	:	_
96-20	15878-15881	the	_
96-21	15882-15887	model	_
96-22	15888-15893	where	_
96-23	15894-15902	loadings	_
96-24	15903-15910	samples	_
96-25	15911-15913	in	_
96-26	15914-15917	the	_
96-27	15918-15921	SCZ	_
96-28	15922-15925	and	_
96-29	15926-15928	HC	_
96-30	15929-15933	were	_
96-31	15934-15945	constrained	_
96-32	15946-15948	to	_
96-33	15949-15951	be	_
96-34	15952-15957	equal	_
96-35	15958-15961	and	_
96-36	15962-15965	the	_
96-37	15966-15971	other	_
96-38	15972-15977	model	_
96-39	15978-15983	where	_
96-40	15984-15988	they	_
96-41	15989-15993	were	_
96-42	15994-16001	allowed	_
96-43	16002-16004	to	_
96-44	16005-16011	differ	_
96-45	16012-16013	(	_
96-46	16014-16027	unconstrained	_
96-47	16028-16029	)	_
96-48	16030-16035	using	_
96-49	16036-16039	the	_
96-50	16040-16050	likelihood	_
96-51	16051-16056	ratio	_
96-52	16057-16061	test	_
96-53	16062-16063	(	_
96-54	16064-16065	a	_
96-55	16066-16067	2	_
96-56	16068-16078	difference	_
96-57	16079-16083	test	_
96-58	16084-16085	)	_
96-59	16086-16087	.	_

97-1	16088-16090	In	_
97-2	16091-16094	the	_
97-3	16095-16102	present	_
97-4	16103-16108	study	_
97-5	16109-16110	,	_
97-6	16111-16113	we	_
97-7	16114-16122	compared	_
97-8	16123-16126	the	_
97-9	16127-16130	fit	_
97-10	16131-16138	between	_
97-11	16139-16142	the	_
97-12	16143-16156	unconstrained	_
97-13	16157-16162	model	_
97-14	16163-16166	and	_
97-15	16167-16170	the	_
97-16	16171-16176	model	_
97-17	16177-16188	constrained	_
97-18	16189-16191	to	_
97-19	16192-16194	be	_
97-20	16195-16200	equal	_
97-21	16201-16203	to	_
97-22	16204-16207	the	_
97-23	16208-16216	observed	_
97-24	16217-16220	and	_
97-25	16221-16226	error	_
97-26	16227-16236	variables	_
97-27	16237-16238	.	_

98-1	16239-16241	To	_
98-2	16242-16249	perform	_
98-3	16250-16253	the	_
98-4	16254-16264	likelihood	_
98-5	16265-16270	ratio	_
98-6	16271-16275	test	_
98-7	16276-16279	for	_
98-8	16280-16283	MLR	_
98-9	16284-16285	,	_
98-10	16286-16288	we	_
98-11	16289-16299	calculated	_
98-12	16300-16303	the	_
98-13	16304-16306	χ2	_
98-14	16307-16312	value	_
98-15	16313-16315	of	_
98-16	16316-16331	Satorra-Bentler	_
98-17	16332-16333	(	_
98-18	16334-16340	M-plus	_
98-19	16341-16348	website	_
98-20	16349-16350	:	_
98-21	16351-16356	https	_
98-22	16357-16358	:	_
98-23	16359-16392	//www.statmodel.com/chidiff.shtml	_
98-24	16393-16394	)	_
98-25	16395-16396	.	_

99-1	16397-16400	The	_
99-2	16401-16416	Satorra-Bentler	_
99-3	16417-16423	scaled	_
99-4	16424-16434	chi-square	_
99-5	16435-16445	difference	_
99-6	16446-16450	test	_
99-7	16451-16454	TRd	_
99-8	16455-16463	computed	_
99-9	16464-16466	as	_
99-10	16467-16474	follows	_
99-11	16475-16476	;	_
99-12	16477-16482	where	_
99-13	16483-16485	T0	_
99-14	16486-16489	and	_
99-15	16490-16492	T1	_
99-16	16493-16496	are	_
99-17	16497-16500	the	_
99-18	16501-16504	MLR	_
99-19	16505-16515	chi-square	_
99-20	16516-16522	values	_
99-21	16523-16526	for	_
99-22	16527-16530	the	_
99-23	16531-16537	nested	_
99-24	16538-16541	and	_
99-25	16542-16552	comparison	_
99-26	16553-16558	model	_
99-27	16559-16560	,	_
99-28	16561-16573	respectively	_
99-29	16574-16575	.	_

100-1	16576-16579	The	_
100-2	16580-16590	difference	_
100-3	16591-16595	test	_
100-4	16596-16603	scaling	_
100-5	16604-16614	correction	_
100-6	16615-16616	(	_
100-7	16617-16619	cd	_
100-8	16620-16621	)	_
100-9	16622-16625	was	_
100-10	16626-16634	computed	_
100-11	16635-16637	as	_
100-12	16638-16645	follows	_
100-13	16646-16647	;	_
100-14	16648-16653	where	_
100-15	16654-16656	d0	_
100-16	16657-16659	is	_
100-17	16660-16663	the	_
100-18	16664-16671	degrees	_
100-19	16672-16674	of	_
100-20	16675-16682	freedom	_
100-21	16683-16685	in	_
100-22	16686-16689	the	_
100-23	16690-16696	nested	_
100-24	16697-16702	model	_
100-25	16703-16704	,	_
100-26	16705-16707	c0	_
100-27	16708-16710	is	_
100-28	16711-16714	the	_
100-29	16715-16722	scaling	_
100-30	16723-16733	correction	_
100-31	16734-16740	factor	_
100-32	16741-16744	for	_
100-33	16745-16748	the	_
100-34	16749-16755	nested	_
100-35	16756-16761	model	_
100-36	16762-16763	,	_
100-37	16764-16766	d1	_
100-38	16767-16769	is	_
100-39	16770-16773	the	_
100-40	16774-16781	degrees	_
100-41	16782-16784	of	_
100-42	16785-16792	freedom	_
100-43	16793-16795	in	_
100-44	16796-16799	the	_
100-45	16800-16810	comparison	_
100-46	16811-16816	model	_
100-47	16817-16818	,	_
100-48	16819-16822	and	_
100-49	16823-16825	c1	_
100-50	16826-16828	is	_
100-51	16829-16832	the	_
100-52	16833-16840	scaling	_
100-53	16841-16851	correction	_
100-54	16852-16858	factor	_
100-55	16859-16862	for	_
100-56	16863-16866	the	_
100-57	16867-16877	comparison	_
100-58	16878-16883	model	_
100-59	16884-16885	.	_

101-1	16886-16897	Statistical	_
101-2	16898-16906	analysis	_
101-3	16907-16911	PASW	_
101-4	16912-16922	Statistics	_
101-5	16923-16930	version	_
101-6	16931-16935	18.0	_
101-7	16936-16937	(	_
101-8	16938-16942	SPSS	_
101-9	16943-16944	,	_
101-10	16945-16952	Chicago	_
101-11	16953-16954	,	_
101-12	16955-16957	IL	_
101-13	16958-16959	,	_
101-14	16960-16963	USA	_
101-15	16964-16965	)	_
101-16	16966-16969	was	_
101-17	16970-16974	used	_
101-18	16975-16978	for	_
101-19	16979-16982	the	_
101-20	16983-16991	analysis	_
101-21	16992-16993	,	_
101-22	16994-16997	and	_
101-23	16998-17001	the	_
101-24	17002-17007	level	_
101-25	17008-17010	of	_
101-26	17011-17023	significance	_
101-27	17024-17027	was	_
101-28	17028-17031	set	_
101-29	17032-17034	at	_
101-30	17035-17039	0.05	_
101-31	17040-17041	.	_

102-1	17042-17054	Mann-Whitney	_
102-2	17055-17056	U	_
102-3	17057-17061	test	_
102-4	17062-17065	was	_
102-5	17066-17070	used	_
102-6	17071-17073	to	_
102-7	17074-17081	explore	_
102-8	17082-17095	between-group	_
102-9	17096-17107	differences	_
102-10	17108-17111	for	_
102-11	17112-17115	the	_
102-12	17116-17127	demographic	_
102-13	17128-17131	and	_
102-14	17132-17140	clinical	_
102-15	17141-17156	characteristics	_
102-16	17157-17158	,	_
102-17	17159-17162	the	_
102-18	17163-17170	correct	_
102-19	17171-17177	trials	_
102-20	17178-17179	,	_
102-21	17180-17183	the	_
102-22	17184-17188	mean	_
102-23	17189-17191	RT	_
102-24	17192-17193	,	_
102-25	17194-17197	and	_
102-26	17198-17201	the	_
102-27	17202-17205	IMI	_
102-28	17206-17212	scores	_
102-29	17213-17214	.	_

103-1	17215-17222	Two-way	_
103-2	17223-17228	mixed	_
103-3	17229-17234	ANOVA	_
103-4	17235-17238	was	_
103-5	17239-17243	used	_
103-6	17244-17246	to	_
103-7	17247-17254	examine	_
103-8	17255-17268	between-group	_
103-9	17269-17280	differences	_
103-10	17281-17284	for	_
103-11	17285-17288	the	_
103-12	17289-17293	mean	_
103-13	17294-17296	TE	_
103-14	17297-17298	,	_
103-15	17299-17302	the	_
103-16	17303-17314	performance	_
103-17	17315-17320	level	_
103-18	17321-17330	following	_
103-19	17331-17341	Undershoot	_
103-20	17342-17344	or	_
103-21	17345-17354	Overshoot	_
103-22	17355-17361	trials	_
103-23	17362-17363	.	_

104-1	17364-17371	Pearson	_
104-2	17372-17374	's	_
104-3	17375-17376	r	_
104-4	17377-17380	was	_
104-5	17381-17391	calculated	_
104-6	17392-17395	for	_
104-7	17396-17400	each	_
104-8	17401-17406	group	_
104-9	17407-17409	to	_
104-10	17410-17417	examine	_
104-11	17418-17421	the	_
104-12	17422-17433	correlation	_
104-13	17434-17441	between	_
104-14	17442-17445	the	_
104-15	17446-17457	performance	_
104-16	17458-17461	and	_
104-17	17462-17465	the	_
104-18	17466-17476	difference	_
104-19	17477-17479	of	_
104-20	17480-17483	IMI	_
104-21	17484-17490	scores	_
104-22	17491-17493	in	_
104-23	17494-17497	the	_
104-24	17498-17500	SW	_
104-25	17501-17504	and	_
104-26	17505-17507	WS	_
104-27	17508-17513	tasks	_
104-28	17514-17515	.	_

105-1	17516-17519	The	_
105-2	17520-17524	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
105-3	17525-17529	data	_
105-4	17530-17534	were	_
105-5	17535-17543	analyzed	_
105-6	17544-17546	as	_
105-7	17547-17556	described	_
105-8	17557-17562	above	_
105-9	17563-17565	in	_
105-10	17566-17569	the	_
105-11	17570-17574	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
105-12	17575-17579	data	_
105-13	17580-17588	analysis	_
105-14	17589-17596	section	_
105-15	17597-17598	.	_

106-1	17599-17606	Pearson	_
106-2	17607-17609	's	_
106-3	17610-17611	r	_
106-4	17612-17615	was	_
106-5	17616-17626	calculated	_
106-6	17627-17630	for	_
106-7	17631-17635	each	_
106-8	17636-17641	group	_
106-9	17642-17644	to	_
106-10	17645-17652	examine	_
106-11	17653-17656	the	_
106-12	17657-17668	correlation	_
106-13	17669-17676	between	_
106-14	17677-17680	the	_
106-15	17681-17691	activation	_
106-16	17692-17694	in	_
106-17	17695-17698	the	_
106-18	17699-17707	striatum	_
106-19	17708-17710	or	_
106-20	17711-17715	LPFC	_
106-21	17716-17719	and	_
106-22	17720-17723	the	_
106-23	17724-17734	difference	_
106-24	17735-17737	of	_
106-25	17738-17741	IMI	_
106-26	17742-17748	scores	_
106-27	17749-17756	between	_
106-28	17757-17760	the	_
106-29	17761-17763	SW	_
106-30	17764-17767	and	_
106-31	17768-17770	WS	_
106-32	17771-17776	tasks	_
106-33	17777-17778	,	_
106-34	17779-17782	and	_
106-35	17783-17786	the	_
106-36	17787-17798	correlation	_
106-37	17799-17806	between	_
106-38	17807-17810	the	_
106-39	17811-17821	activation	_
106-40	17822-17824	in	_
106-41	17825-17828	the	_
106-42	17829-17837	striatum	_
106-43	17838-17840	or	_
106-44	17841-17845	LPFC	_
106-45	17846-17849	and	_
106-46	17850-17853	the	_
106-47	17854-17858	rate	_
106-48	17859-17861	of	_
106-49	17862-17869	Success	_
106-50	17870-17872	SW	_
106-51	17873-17879	trials	_
106-52	17880-17889	following	_
106-53	17890-17900	Undershoot	_
106-54	17901-17903	or	_
106-55	17904-17913	Overshoot	_
106-56	17914-17920	trials	_
106-57	17921-17922	.	_

107-1	17923-17925	In	_
107-2	17926-17934	addition	_
107-3	17935-17936	,	_
107-4	17937-17944	Pearson	_
107-5	17945-17947	's	_
107-6	17948-17949	r	_
107-7	17950-17953	was	_
107-8	17954-17964	calculated	_
107-9	17965-17972	between	_
107-10	17973-17976	the	_
107-11	17977-17980	IMI	_
107-12	17981-17982	(	_
107-13	17983-17988	SW-WS	_
107-14	17989-17990	)	_
107-15	17991-17992	,	_
107-16	17993-18004	performance	_
107-17	18005-18010	level	_
107-18	18011-18012	,	_
107-19	18013-18018	error	_
107-20	18019-18029	correction	_
107-21	18030-18031	,	_
107-22	18032-18040	striatum	_
107-23	18041-18042	,	_
107-24	18043-18047	LPFC	_
107-25	18048-18049	β	_
107-26	18050-18051	(	_
107-27	18052-18057	SW-WS	_
107-28	18058-18059	)	_
107-29	18060-18063	and	_
107-30	18064-18078	Chlorpromazine	_
107-31	18079-18080	(	_
107-32	18081-18083	CP	_
107-33	18084-18085	)	_
107-34	18086-18096	equivalent	_
107-35	18097-18102	daily	_
107-36	18103-18109	dosage	_
107-37	18110-18112	of	_
107-38	18113-18127	antipsychotics	http://maven.renci.org/NeuroBridge/neurobridge#PhysicalMeasurement
107-39	18128-18131	and	http://maven.renci.org/NeuroBridge/neurobridge#PhysicalMeasurement
107-40	18132-18140	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-41	18141-18144	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-42	18145-18153	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-43	18154-18162	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-44	18163-18168	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-45	18169-18170	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-46	18171-18176	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-47	18177-18178	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
107-48	18179-18187	negative	_
107-49	18188-18194	scores	_
107-50	18195-18196	.	_

108-1	18197-18209	Multiplicity	_
108-2	18210-18212	of	_
108-3	18213-18224	statistical	_
108-4	18225-18233	analyses	_
108-5	18234-18237	was	_
108-6	18238-18247	corrected	_
108-7	18248-18253	using	_
108-8	18254-18264	Bonferroni	_
108-9	18265-18268	for	_
108-10	18269-18273	each	_
108-11	18274-18278	test	_
108-12	18279-18280	.	_

